Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.5154976448298197e-36,27.60657767576709,2276.916526833105,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",9.07783089253062e-34,0,0,79
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.171206269578684e-17,6.628840601169764,258.43139874924145,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'UCP1', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'UCP3', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",3.5077627773881584e-15,0,0,62
3,Oxidative phosphorylation WP623,1.0676523528105909e-11,7.3103666245259165,184.681600852766,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1B', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",2.1317458644451466e-09,0,0,37
4,"GPCRs, Class A Rhodopsin-like WP455",1.4787892105143543e-08,2.7720269619643716,49.97814116862429,"['NPFFR2', 'GPR27', 'OXTR', 'CHRM1', 'GPR68', 'GPR22', 'CHRM5', 'NPY2R', 'HTR2B', 'GPR20', 'ADRA1D', 'ADRA1B', 'ADRA1A', 'MC4R', 'EDNRA', 'HTR7', 'GPER1', 'GPR171', 'PTGDR', 'GPR34', 'GPR35', 'OR2H2', 'F2R', 'SSTR1', 'SSTR3', 'TRHR', 'ADORA2A', 'OR3A3', 'OR3A2', 'OPRD1', 'PTGER2', 'GPR87', 'PTGER3', 'OPRL1', 'FPR3', 'GPR83', 'MCHR1', 'HRH1', 'P2RY6', 'GALR3', 'OR2AG1', 'RHO', 'DRD2', 'DRD3', 'NTSR1', 'DRD5', 'P2RY12', 'P2RY13', 'HTR1E', 'P2RY14', 'GPR52', 'GPR1', 'GPR3', 'GPR6', 'HTR5A', 'HCRTR2', 'HCRTR1', 'MAS1', 'OPN1SW', 'LPAR6', 'ACKR4', 'NMUR2', 'RGL4', 'GPR18']",2.2144868427452455e-06,0,0,64
5,Mitochondrial complex I assembly model OXPHOS system WP4324,3.5278259505161364e-08,4.9099113446939535,84.25407347426557,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'DMAC2', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM186', 'TMEM70', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",4.226335488718331e-06,0,0,32
6,Nonalcoholic fatty liver disease WP4396,1.155956704255941e-06,2.3513520640236267,32.144351769911715,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'NDUFA12', 'COX4I1', 'PRKAG2', 'COX6A1', 'COX7C', 'CASP8', 'LEPR', 'MLX', 'UQCRFS1', 'RAC1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'ATF4', 'CEBPA', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'SOCS3', 'CYC1', 'NDUFV1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'LEP', 'NDUFAB1', 'CYCS', 'BAX']",0.00011540301097488477,0,0,62
7,Mitochondrial CIV Assembly WP4922,4.551434111807049e-06,5.261940347001104,64.72222505485804,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'SCO2', 'COX14', 'COX20']",0.0003894727189960603,0,0,21
8,Glycolysis and Gluconeogenesis WP534,4.843749699772177e-05,3.789114632983794,37.645749295108345,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'SLC2A3', 'ENO1', 'ENO2', 'HK2', 'GCK', 'LDHC', 'LDHB', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'FBP1', 'PFKM', 'GAPDH', 'FBP2']",0.0036267575877044177,0,0,22
9,Sleep regulation WP3591,6.67842393824724e-05,4.507012987012987,43.33061865371896,"['CHRNB2', 'OXTR', 'NLGN1', 'AHCY', 'NPY2R', 'IL18', 'FOS', 'NPAS2', 'HCRTR2', 'HCRTR1', 'STAR', 'ADORA2A', 'CRH', 'GHRL', 'DRD2', 'PTGDS', 'DRD3', 'PTGDR']",0.004444862154455663,0,0,18
10,Cellular Proteostasis WP4918,0.00036144819693634223,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.0216507469964869,0,0,6
11,"GPCRs, Other WP117",0.0009068457746685727,2.3998891634146906,16.812515117099704,"['GPR88', 'ADRA1D', 'GPR83', 'CELSR2', 'GRM1', 'ADGRE2', 'EDNRA', 'PROKR2', 'HTR7', 'HRH4', 'GNRHR', 'DRD3', 'NTSR1', 'GPR135', 'P2RY13', 'ADGRV1', 'F2R', 'GPR55', 'SMO', 'ADORA2A', 'GPR183', 'OR10A2', 'LGR6', 'OR3A3', 'ADGRL2', 'GPR18', 'ADGRL3']",0.04547552208302988,0,0,27
12,Exercise-induced Circadian Regulation WP410,0.0009110288230323182,2.639700039729837,18.48037109624024,"['IDI1', 'DAZAP2', 'HSPA8', 'CEBPB', 'BTG1', 'RBPMS', 'GSTP1', 'NCOA4', 'G0S2', 'GFRA1', 'QKI', 'AZIN1', 'HERPUD1', 'PER2', 'DNAJA1', 'CLDN5', 'SUMO1', 'TUBB3', 'STBD1', 'UCP3', 'SUMO3', 'ERC2', 'EIF4G2']",0.04547552208302988,0,0,23
13,Vitamin D Receptor Pathway WP2877,0.001256875673298501,1.8264137691167384,12.198848170120293,"['COLEC11', 'CEBPA', 'CDKN1A', 'STEAP4', 'ABCB1', 'CDKN1B', 'COL13A1', 'HILPDA', 'TNFRSF11B', 'PRDM1', 'GXYLT2', 'CLDN2', 'EFNA5', 'ADRA1B', 'CYP3A4', 'CYP3A5', 'FOXO1', 'KNG1', 'THBD', 'SULT1C2', 'ADAMTS5', 'MYC', 'CREG2', 'BTLA', 'TIMP2', 'TIMP3', 'SOSTDC1', 'LGALS9', 'JUNB', 'CDKN2D', 'SLC37A2', 'SERPINB1', 'CDKN2B', 'TGFB1', 'CDKN2C', 'IGFBP5', 'GADD45A', 'NFATC2', 'G0S2', 'MYO9B', 'BMP6', 'CEACAM1', 'TNFSF4', 'S100A6', 'CLPTM1L', 'HLA-DRB1', 'NOX1']",0.05714004661900438,0,0,47
14,Blood Clotting Cascade WP272,0.0013825622538387468,5.500950570342205,36.21725075722534,"['F7', 'F8A1', 'SERPINB2', 'F10', 'F12', 'SERPINF2', 'PLG', 'PLAT', 'KLKB1', 'F5']",0.05714004661900438,0,0,10
15,Selenium Micronutrient Network WP15,0.0014308859754341666,2.1755768360729903,14.248856648351076,"['SERPINA3', 'PLAT', 'PLG', 'TXN', 'SELENOK', 'MPO', 'PTGS1', 'SELENOH', 'PRDX3', 'PRDX5', 'RFK', 'PRDX1', 'PNPO', 'SEPHS2', 'ABCA1', 'GPX2', 'GPX4', 'GPX3', 'DIO1', 'DIO2', 'APOA1', 'KMO', 'SOD3', 'SOD1', 'F7', 'SELENOM', 'SELENOS', 'SELENOW', 'SELENOT', 'MSRB1']",0.05714004661900438,0,0,30
16,Spinal Cord Injury WP2431,0.0016335122834046055,1.920303045841452,12.322628442028764,"['BTG2', 'CDKN1B', 'XYLT1', 'NTN1', 'RTN4', 'EGFR', 'TNFSF13B', 'LGALS3', 'ACAN', 'ZFP36', 'PRB1', 'MYC', 'E2F1', 'SLIT3', 'NOS1', 'RAC1', 'ROS1', 'MAPK3', 'EGR1', 'TGFB1', 'GADD45A', 'BDNF', 'OMG', 'MIF', 'FOS', 'PDYN', 'LILRB3', 'GFAP', 'RHOB', 'SELP', 'FKBP1A', 'BCAN', 'NR4A1', 'VCAN', 'LEP', 'APEX1', 'CDK1', 'CSPG4', 'LTB']",0.06115461610995992,0,0,39
17,Computational Model of Aerobic Glycolysis WP4629,0.001891197820956205,7.3323832145684875,45.97803804597629,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH', 'PFKM']",0.0666369114560451,0,0,8
18,Complement and Coagulation Cascades WP558,0.0022327718739294867,2.5139696056189202,15.346556299249798,"['CPB2', 'CFH', 'SERPIND1', 'F10', 'F12', 'SERPINF2', 'F2R', 'C5AR1', 'PLAT', 'PLG', 'TFPI', 'CLU', 'KNG1', 'F5', 'C3', 'THBD', 'F7', 'C6', 'C9', 'MASP2', 'KLKB1']",0.07430168624909791,0,0,21
19,Drug Induction of Bile Acid Pathway WP2289,0.004345085206471999,5.498812351543943,29.906445230792347,"['ABCC3', 'ABCB1', 'ABCC2', 'SLC10A1', 'NR1I3', 'SLC51A', 'CYP3A4', 'ABCB11']",0.1369845283514067,0,0,8
20,Thyroxine (Thyroid Hormone) Production WP1981,0.005077723763553682,inf,inf,"['TPO', 'TG', 'CGA', 'TSHR']",0.15207782671843278,0,0,4
21,Globo Sphingolipid Metabolism WP1424,0.006766341507755554,3.3613290019280035,16.792509733117537,"['B3GALNT1', 'ST6GALNAC1', 'ST6GAL1', 'ST6GAL2', 'ST6GALNAC2', 'B3GALT5', 'FUT2', 'ST6GALNAC3', 'FUT1', 'ABO', 'ST6GALNAC5']",0.19300183634026558,0,0,11
22,Pyrimidine metabolism WP4022,0.009869754476571195,1.762675585284281,8.140529933582915,"['DPYS', 'TYMP', 'NT5C', 'POLD4', 'ZNRD1', 'POLD1', 'POLD2', 'POLR2E', 'ENPP1', 'TK1', 'POLR2I', 'POLE', 'POLR2J', 'POLR2K', 'POLR2L', 'ENTPD1', 'RRM2', 'POLR2J2', 'NME2', 'NME3', 'NME1', 'POLE4', 'RRM2B', 'POLE2', 'POLR1C', 'DPYD', 'POLE3', 'POLR1E', 'CMPK2', 'POLR3H', 'DCTPP1', 'POLR3K']",0.2372520312160528,0,0,32
23,Peptide GPCRs WP24,0.0099443057701591,2.178544494720965,10.0447353052572,"['OPRD1', 'OXTR', 'NPY2R', 'C5AR1', 'TACR2', 'OPRL1', 'FPR3', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2', 'TRHR', 'HCRTR1', 'MC4R', 'EDNRA', 'GALR3', 'GNRHR', 'TAC4', 'NTSR1']",0.2372520312160528,0,0,19
24,Proximal tubule transport WP4917,0.010221573704737778,2.1169421336167407,9.702485032660476,"['ATP6V1A', 'SLC47A2', 'ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'ABCC2', 'ABCB1', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'SLC5A2', 'SLC7A9', 'FXYD2', 'ATP6V0A4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1B1', 'ATP6V1F']",0.2372520312160528,0,0,20
25,Endochondral Ossification with Skeletal Dysplasias WP4808,0.010649665584716438,1.9784043504171633,8.986361237596192,"['TGFB1', 'HMGCS1', 'STAT1', 'PTCH1', 'PLAT', 'PTH1R', 'CTSV', 'GLI3', 'BMP6', 'IGF1R', 'GHR', 'ADAMTS5', 'ACAN', 'ADAMTS1', 'MGP', 'COL10A1', 'ENPP1', 'TIMP3', 'ALPL', 'CALM1', 'CALM2', 'FGFR3', 'SOX5']",0.2372520312160528,0,0,23
26,Endochondral Ossification WP474,0.010649665584716438,1.9784043504171633,8.986361237596192,"['TGFB1', 'HMGCS1', 'STAT1', 'PTCH1', 'PLAT', 'PTH1R', 'CTSV', 'GLI3', 'BMP6', 'IGF1R', 'GHR', 'ADAMTS5', 'ACAN', 'ADAMTS1', 'MGP', 'COL10A1', 'ENPP1', 'TIMP3', 'ALPL', 'CALM1', 'CALM2', 'FGFR3', 'SOX5']",0.2372520312160528,0,0,23
27,Pregnane X receptor pathway WP2876,0.010819839252421685,3.0249346327549325,13.691985056556742,"['ABCC3', 'HSP90AA1', 'PSMC5', 'CYP2A6', 'ABCB1', 'ABCC2', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1', 'CYP3A7']",0.2372520312160528,0,0,11
28,Transcriptional cascade regulating adipogenesis WP4211,0.011090245198747042,4.810318214200902,21.654558361412196,"['CEBPA', 'CEBPB', 'EGR2', 'KLF5', 'DDIT3', 'PPARG', 'KLF15']",0.2372520312160528,0,0,7
29,Ferroptosis WP4313,0.012482071959901857,2.2272021400800264,9.762855741105009,"['PRNP', 'GPX4', 'ALOX15', 'NCOA4', 'ACSL5', 'SAT2', 'SLC7A11', 'CP', 'MAP1LC3B', 'TF', 'MAP1LC3A', 'FTH1', 'PCBP1', 'VDAC3', 'HMOX1', 'VDAC2', 'FTL']",0.25781934841314524,0,0,17
30,Monoamine GPCRs WP58,0.013744908001777831,2.5538474605062,10.948565866376931,"['CHRM1', 'HTR1E', 'CHRM5', 'HTR2B', 'ADRA1D', 'ADRA1B', 'HTR5A', 'ADRA1A', 'HRH1', 'HTR7', 'DRD2', 'DRD3', 'DRD5']",0.2707631003447895,0,0,13
31,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.014012781486959055,5.49667616334283,23.458634292240433,"['SOCS3', 'CDH1', 'MYC', 'E2F1', 'CHI3L1', 'BAX']",0.2707631003447895,0,0,6
32,Complement system WP2806,0.019392151318149562,1.7128188809334395,6.753451069474891,"['FKBP2', 'SELPLG', 'CFH', 'C5AR1', 'C4BPA', 'ADM', 'PLG', 'TXN', 'THBS1', 'C3', 'GNA15', 'C6', 'RPS19', 'C9', 'C1QBP', 'CD59', 'VSIG4', 'PRNP', 'F10', 'F12', 'APOA1', 'SELE', 'SELP', 'SELL', 'MASP2', 'PTX3', 'CALR', 'KLKB1']",0.32783126017527614,0,0,28
33,Aryl Hydrocarbon Receptor Pathway WP2873,0.01949829703732815,2.3833848592944906,9.384406634040705,"['HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'SERPINB2', 'AIP', 'EGFR', 'CDC37', 'CYP1B1', 'AHRR', 'BAX', 'HES1', 'JUNB']",0.32783126017527614,0,0,13
34,Adipogenesis WP236,0.019644642996189232,1.5567485460428436,6.11794488084815,"['CEBPA', 'CDKN1A', 'CEBPB', 'EPAS1', 'ASIP', 'UCP1', 'LPL', 'RORA', 'FOXO1', 'LIPE', 'SOCS3', 'CYP26B1', 'E2F1', 'NDN', 'MEF2D', 'PCK2', 'GDF10', 'WWTR1', 'EGR2', 'TGFB1', 'WNT5B', 'GADD45B', 'GADD45A', 'STAT1', 'EBF1', 'HMGA1', 'MIF', 'PRLR', 'KLF15', 'BSCL2', 'SFRP4', 'BMP3', 'RBL1', 'KLF5', 'DDIT3', 'LEP', 'ID3', 'PPARG', 'PLIN1']",0.32783126017527614,0,0,39
35,IL-18 signaling pathway WP4754,0.019684702139266666,1.3694096511801985,5.378922636806537,"['BTG2', 'CD83', 'CD81', 'NCF2', 'HSPB8', 'HSPB1', 'ENO1', 'RND2', 'RPTOR', 'ADAMTS5', 'CASP8', 'TMSB4X', 'FAM186B', 'STMN1', 'NPPA', 'TIMP3', 'RPS11', 'IER3', 'TICAM2', 'USP5', 'IMP3', 'IL18', 'NDUFC1', 'FOS', 'BPGM', 'ACTA2', 'ARL4D', 'ACTA1', 'CLDN4', 'RFX5', 'LTB', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'TSHZ1', 'MEPCE', 'COX17', 'TNFRSF11B', 'ACACB', 'FUT1', 'CENPB', 'CCNB2', 'SOCS3', 'IRAK1', 'HMOX1', 'FADD', 'ABCF1', 'MAPK3', 'SLC12A3', 'JUN', 'BAD', 'FN1', 'CFLAR', 'EEF2', 'COL1A1', 'NFKBIA', 'NR4A1', 'TF', 'NACA', 'BCL2', 'CYCS', 'BAX', 'PTX3', 'PTPN7', 'NFKBIE', 'NOX1', 'CDK5R2', 'SNTB1', 'AARS', 'ITM2C']",0.32783126017527614,0,0,72
36,Nuclear Receptors Meta-Pathway WP2882,0.019702713466293723,1.3456483042355798,5.2843594284408235,"['CDKN1B', 'SRXN1', 'KEAP1', 'SLC2A3', 'SLC7A11', 'THBD', 'CPT2', 'ZIC2', 'MYC', 'FTH1', 'ENC1', 'CYP1B1', 'SLC39A7', 'JUNB', 'SLC39A1', 'SLC39A4', 'SLC39A3', 'ABCC3', 'HSP90AA1', 'GPX2', 'SERPINB2', 'ABCC2', 'GPX3', 'TSC22D3', 'HGF', 'SLC2A12', 'SLC39A11', 'AIP', 'APOA1', 'NRG1', 'SLC39A12', 'CES4A', 'TGFBR2', 'TGFBR3', 'CYP2A6', 'SLC5A9', 'NAV3', 'CDC37', 'B3GNT5', 'AHRR', 'BLVRB', 'ANGPTL4', 'FKBP5', 'FTL', 'ABCB1', 'ABCB4', 'GSTP1', 'NR1I3', 'AMIGO2', 'SLC5A12', 'TXN', 'SLC5A2', 'ABCB11', 'CYP2C19', 'CYP3A4', 'SLC5A3', 'CYP3A5', 'SLC5A4', 'EGFR', 'FOXO1', 'CYP3A7', 'PRDX1', 'HMOX1', 'HES1', 'CBR3', 'EGR1', 'JUN', 'TGFB1', 'GADD45B', 'SLC10A1', 'PLK2', 'SOD3', 'SLC2A9', 'PSMC5', 'BHLHE40', 'MAFF', 'CDK1', 'SPINK13', 'BAX', 'SPRY1']",0.32783126017527614,0,0,80
37,NRF2 pathway WP2884,0.02289227488465309,1.5343759614398522,5.79527013571697,"['SRXN1', 'GSTP1', 'KEAP1', 'SLC5A12', 'SLC2A3', 'TXN', 'SLC7A11', 'SLC5A2', 'SLC5A3', 'SLC5A4', 'FTH1', 'PRDX1', 'HMOX1', 'SLC39A7', 'SLC39A1', 'SLC39A4', 'SLC39A3', 'CBR3', 'ABCC3', 'EGR1', 'HSP90AA1', 'GPX2', 'TGFB1', 'ABCC2', 'GPX3', 'HGF', 'SLC2A12', 'SLC39A11', 'NRG1', 'SLC39A12', 'SOD3', 'CES4A', 'TGFBR2', 'SLC2A9', 'CYP2A6', 'SLC5A9', 'MAFF', 'BLVRB', 'FTL']",0.370607369078573,0,0,39
38,Mitochondrial complex III assembly WP4921,0.025587074695439214,3.141364099083814,11.515197696375756,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.3929912241684126,0,0,8
39,TP53 network WP1742,0.025587074695439214,3.141364099083814,11.515197696375756,"['CDKN1A', 'SUMO1', 'GADD45A', 'MYC', 'ABL1', 'BCL2', 'BAX', 'TP63']",0.3929912241684126,0,0,8
40,Cytokines and Inflammatory Response WP530,0.027177530610988487,4.122150997150997,14.861857806767604,"['CD4', 'TGFB1', 'IL5', 'IL15', 'IL7', 'HLA-DRB1']",0.3970570935605391,0,0,6
41,EDA signaling in hair follicle development WP3930,0.027177530610988487,4.122150997150997,14.861857806767604,"['EDA', 'PTCH1', 'SOSTDC1', 'LTB', 'DKK1', 'RELB']",0.3970570935605391,0,0,6
42,Nanomaterial induced apoptosis WP2507,0.02935756216150017,2.748871465906391,9.698582356399225,"['ENDOG', 'CASP8', 'CASP6', 'BCL2', 'HTRA2', 'BAX', 'CYCS', 'CFLAR', 'FADD']",0.41869475558901437,0,0,9
43,Canonical and non-canonical Notch signaling WP3845,0.03402213179639709,2.3262694044723995,7.8645214035382836,"['NOTCH3', 'NOTCH1', 'MAML2', 'HEY1', 'RRAS', 'MAML1', 'CNTN6', 'NOTCH4', 'HES1', 'DLL3', 'DLK2']",0.47393620804748504,0,0,11
44,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.035939126234677564,4.57947622438484,15.23101145007398,"['HSD11B1', 'HSD11B2', 'STAR', 'CYP21A2', 'HSD3B1']",0.4892621957857241,0,0,5
45,Serotonin and anxiety WP3947,0.039420775251961644,2.7484560570071257,8.887029073739761,"['POMC', 'GABRA1', 'ARC', 'CRH', 'TRPV1', 'FOS', 'ADRA1A', 'GRM1']",0.5247343194650006,0,0,8
46,Imatinib and Chronic Myeloid Leukemia WP3640,0.04285069070677665,2.4737704918032786,7.792459957326928,"['SPRED2', 'ABCB1', 'CDKN1B', 'FLT1', 'GADD45A', 'MYC', 'ABL1', 'PIM2', 'SKP2']",0.534169692643251,0,0,9
47,Inflammatory Response Pathway WP453,0.04285069070677665,2.4737704918032786,7.792459957326928,"['COL1A1', 'ZAP70', 'IL4R', 'IL5', 'LAMB2', 'CD80', 'FN1', 'TNFRSF1B', 'THBS1']",0.534169692643251,0,0,9
48,Constitutive Androstane Receptor Pathway WP2875,0.045095717517302354,2.2906764892268696,7.0987331207193956,"['ABCC3', 'HSP90AA1', 'CYP2A6', 'ABCB1', 'ABCC2', 'NR1I3', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1']",0.534169692643251,0,0,10
49,Glycolysis in senescence WP5049,0.04648229928941627,3.2974358974358973,10.118787787951717,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.534169692643251,0,0,6
50,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.04648229928941627,3.2974358974358973,10.118787787951717,"['ZAP70', 'CD4', 'CD8B', 'IGLL1', 'CD247', 'HLA-DRB1']",0.534169692643251,0,0,6
51,Development of ureteric collection system WP5053,0.04684351479711388,1.8747972227629615,5.738646881809572,"['ROBO2', 'GDF11', 'GFRA1', 'ETV4', 'GLI3', 'PAX2', 'ROBO1', 'GLI2', 'GRIP1', 'FRAS1', 'SMO', 'ITGA8', 'SPRY1', 'FAT4', 'FREM1']",0.534169692643251,0,0,15
52,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.04726376245424425,5.494542002847651,16.769404822667802,"['CYP2J2', 'COX8A', 'GSTP1', 'COX5A']",0.534169692643251,0,0,4
53,Codeine and Morphine Metabolism WP1604,0.04726376245424425,5.494542002847651,16.769404822667802,"['ABCC3', 'ABCB1', 'ABCC2', 'CYP3A4']",0.534169692643251,0,0,4
54,Galanin receptor pathway WP4970,0.053238296153259396,2.748040845404892,8.059941389089525,"['YAP1', 'POMC', 'CDKN1A', 'CDKN1B', 'UCP1', 'PPARG', 'FOS']",0.5798134435600433,0,0,7
55,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.053238296153259396,2.748040845404892,8.059941389089525,"['CLDN4', 'TGFB1', 'NRG3', 'ERBB4', 'CDH1', 'MYC', 'ALPL']",0.5798134435600433,0,0,7
56,Apoptosis Modulation and Signaling WP1772,0.05628249791623628,1.5159306385403124,4.361895863913865,"['TRADD', 'HTRA2', 'TNFRSF11B', 'BCL2L10', 'CASP8', 'CAPNS1', 'IRAK1', 'CASP6', 'PEA15', 'FADD', 'MAPK3', 'JUN', 'ENDOG', 'CRADD', 'BAD', 'FOS', 'CFLAR', 'TNFRSF1B', 'NFKBIA', 'PTRH2', 'TOLLIP', 'BCL2', 'CYCS', 'BAX', 'PRKD1', 'MAP3K14', 'BCL2L2']",0.6020217187825988,0,0,27
57,Circadian rhythm related genes WP3594,0.0582284862163201,1.3170268096794744,3.7448084672833737,"['CHRM1', 'SUV39H1', 'NPY2R', 'BHLHE41', 'RORA', 'PPP1CC', 'HTR7', 'DBP', 'PTGDS', 'SKP1', 'CHRNB2', 'KLF10', 'KCND2', 'KCNH7', 'CARTPT', 'F7', 'CLDN4', 'ADORA2A', 'CRH', 'PPARG', 'AVP', 'ATF5', 'UBA52', 'ATF4', 'TPH1', 'MAGEL2', 'NLGN1', 'AHCY', 'CIPC', 'OPRL1', 'RBM4B', 'NPAS2', 'RELB', 'ATOH7', 'RAI1', 'PROKR2', 'UBC', 'RPS27A', 'DRD2', 'DRD3', 'NTRK1', 'EGR1', 'JUN', 'EGR3', 'HOMER1', 'CAVIN3', 'HCRTR2', 'NR2F6', 'HCRTR1', 'PER2', 'STAR', 'LEP', 'BHLHE40', 'ID3', 'GHRL']",0.611909881466241,0,0,55
58,7-oxo-C and 7beta-HC pathways WP5064,0.06167037784632457,2.0157515252357183,5.615786112533503,"['HSD11B1', 'CYP27A1', 'HSD11B2', 'DBP', 'ACOX2', 'ACOT11', 'THEM5', 'ACOT12', 'DHCR7', 'ACOT6', 'ACOT4']",0.6324151128266422,0,0,11
59,Role of Osx and miRNAs in tooth development WP3971,0.0633470897656069,3.4343104676002847,9.475696375592836,"['NOTCH3', 'NOTCH1', 'NOTCH4', 'ALPL', 'DKK1']",0.6324151128266422,0,0,5
60,Tamoxifen metabolism WP691,0.0633470897656069,3.4343104676002847,9.475696375592836,"['CYP2A6', 'CYP1B1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.6324151128266422,0,0,5
61,Nicotine Metabolism WP1600,0.07128316735883237,inf,inf,"['CYP2A6', 'AOX1']",0.6999773319334524,0,0,2
62,Biomarkers for pyrimidine metabolism disorders WP4584,0.07743313349780867,2.404327950605557,6.151089592041758,"['NT5C', 'RRM2', 'RRM2B', 'DPYS', 'DPYD', 'CKB', 'TYMP']",0.71186771779246,0,0,7
63,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.07743313349780867,2.404327950605557,6.151089592041758,"['CD63', 'CD81', 'HSPB1', 'PDLIM5', 'EGFR', 'ETS2', 'SOD1']",0.71186771779246,0,0,7
64,miRNAs involved in DNA damage response WP1545,0.07743313349780867,2.404327950605557,6.151089592041758,"['CDKN1A', 'CCND3', 'CDKN1B', 'MYC', 'H2AFX', 'E2F1', 'ABL1']",0.71186771779246,0,0,7
65,Overview of nanoparticle effects WP3287,0.07743313349780867,2.404327950605557,6.151089592041758,"['CCND3', 'CDH3', 'FN1', 'BCL2', 'HMOX1', 'BAX', 'PTGS1']",0.71186771779246,0,0,7
66,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.07843617591703232,1.832461562846727,4.664475990338336,"['NFKBIA', 'NDUFA13', 'HSP90AA1', 'COPS6', 'CASP8', 'ACAP1', 'IL18', 'PRDM1', 'NLRC4', 'RAC1', 'IKBKG', 'AAMP']",0.71186771779246,0,0,12
67,Kynurenine Pathway and links to Cellular Senescence WP5044,0.07992961305903937,2.1983847980997626,5.554458526933056,"['CDKN1A', 'KLF5', 'HAAO', 'NOS1', 'KMO', 'FOXO1', 'ACMSD', 'IDO1']",0.7145946003337997,0,0,8
68,Myometrial relaxation and contraction pathways WP289,0.08278735067072368,1.3161913293473053,3.2792643718452834,"['RYR1', 'OXTR', 'RGS19', 'RGS14', 'YWHAB', 'ITPR2', 'ITPR3', 'ADM', 'RXFP2', 'ETS2', 'ACTB', 'RYR3', 'ACTG1', 'RGS4', 'CNN1', 'GNG3', 'GRK5', 'IGFBP6', 'NOS1', 'RGS6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'GSTO1', 'IGFBP2', 'FOS', 'GNG11', 'ACTA2', 'CREB3', 'ACTA1', 'ADCY9', 'ACTC1', 'PRKAR1A', 'MAFF', 'CRH', 'CALM3', 'PRKD1', 'ATF5', 'CALM1', 'CALM2', 'ATF4']",0.7292591625259336,0,0,44
69,Dual hijack model of Vif in HIV infection WP3300,0.0872852104216987,3.6627115962664134,8.931794152571698,"['UBB', 'ELOB', 'ELOC', 'RUNX1']",0.757736826704312,0,0,4
70,Senescence and Autophagy in Cancer WP615,0.09009173351079383,1.3993960791211737,3.3682440197323076,"['CDKN1A', 'CEBPB', 'SPARC', 'CDKN1B', 'PLAT', 'THBS1', 'GABARAP', 'IGF1R', 'MAP1LC3B', 'MAP1LC3A', 'LAMP1', 'E2F1', 'COL10A1', 'IGFBP7', 'SLC39A1', 'HRAS', 'SLC39A4', 'SLC39A3', 'GABARAPL2', 'GABARAPL1', 'JUN', 'TGFB1', 'SERPINB2', 'IGFBP5', 'FN1', 'HMGA1', 'COL1A1', 'RSL1D1', 'BCL2']",0.7709278338995071,0,0,29
71,ACE Inhibitor Pathway WP554,0.0995166749747655,2.7472110135295513,6.33899727700295,"['MAS1', 'TGFB1', 'ATP6AP2', 'REN', 'KNG1']",0.8011498945811681,0,0,5
72,Selective expression of chemokine receptors during T-cell polarization WP4494,0.0995166749747655,2.7472110135295513,6.33899727700295,"['CD4', 'TGFB1', 'IL4R', 'IL5', 'IL12RB2']",0.8011498945811681,0,0,5
73,Cori Cycle WP1946,0.10504503186717362,2.354904354904355,5.306461750031987,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.8011498945811681,0,0,6
74,Development and heterogeneity of the ILC family WP3893,0.10504503186717362,2.354904354904355,5.306461750031987,"['IL33', 'IL5', 'IL15', 'IL7', 'IL18', 'RORA']",0.8011498945811681,0,0,6
75,Hedgehog Signaling Pathway Netpath WP47,0.10504503186717362,2.354904354904355,5.306461750031987,"['SMO', 'PTCH1', 'SUFU', 'SAP18', 'GLI3', 'GLI2']",0.8011498945811681,0,0,6
76,Zinc homeostasis WP3529,0.10555747141309928,1.9024069302045068,4.277561453047218,"['SLC30A3', 'SLC30A2', 'SLC39A11', 'SLC30A1', 'SLC39A7', 'SLC39A12', 'SLC39A1', 'SLC39A4', 'SLC39A3']",0.8011498945811681,0,0,9
77,Prader-Willi and Angelman Syndrome WP3998,0.10626769311160869,1.492436974789916,3.3457361982088965,"['PCSK1', 'OCA2', 'MAGEL2', 'SLC45A2', 'CDKN2B', 'CDKN2C', 'BDNF', 'ATP10A', 'TYR', 'GABRG3', 'POMC', 'NHLH2', 'GABRR1', 'FEZ1', 'E2F1', 'NDN', 'GHRL', 'CGA', 'GABRD']",0.8011498945811681,0,0,19
78,Metabolic reprogramming in colon cancer WP4290,0.10681332093546228,1.5858178224345247,3.546955323369887,"['MDH2', 'PGAM1', 'PYCR1', 'PYCR2', 'PDHB', 'ENO1', 'ACLY', 'LDHA', 'PKM', 'PGK1', 'ALDOB', 'TKT', 'SLC16A3', 'GAPDH', 'IDH3A']",0.8011498945811681,0,0,15
79,RAS and bradykinin pathways in COVID-19 WP4969,0.10689611505094163,1.9983588857698122,4.468126243319487,"['ROCK1', 'F12', 'REN', 'NOS1', 'CYP3A4', 'KLKB1', 'KNG1', 'PRKG1']",0.8011498945811681,0,0,8
80,Cancer immunotherapy by PD-1 blockade WP4585,0.10699831647160843,2.136995699094963,4.776061823296277,"['ZAP70', 'JUN', 'CD8B', 'NFATC3', 'NFATC2', 'PDCD1LG2', 'HLA-DRB1']",0.8011498945811681,0,0,7
81,Oxysterols derived from cholesterol WP4545,0.11570666541239882,1.624051453896876,3.502586958555287,"['INSIG1', 'ACOT11', 'ACOT12', 'CYP3A4', 'CYP39A1', 'CYP27A1', 'DBP', 'ACOX2', 'GPR183', 'THEM5', 'DHCR7', 'ACOT6', 'ACOT4']",0.8556579331114431,0,0,13
82,miR-517 relationship with ARCN1 and USP1 WP3596,0.1222316606090104,4.119928825622776,8.65941957372501,"['CDKN1A', 'USP1', 'ARCN1']",0.8903643121714139,0,0,3
83,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.12337268432425268,1.4066109473030795,2.943397479503813,"['HSPA8', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBB4B', 'SNCAIP', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1C', 'TUBB6', 'PSMC5', 'CASP8', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMC3', 'TUBB3', 'PSMD2', 'PSMC1', 'PSMD3', 'STUB1']",0.8903643121714139,0,0,22
84,Folate Metabolism WP176,0.12687246210198627,1.526951648293547,3.152503042338549,"['ABCA1', 'SERPINA3', 'GPX2', 'AHCY', 'GPX4', 'GPX3', 'APOA1', 'PLAT', 'PLG', 'MPO', 'SOD3', 'SOD1', 'F7', 'RFK', 'NOS1']",0.89787664951852,0,0,15
85,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.12957472652863916,1.7174132604562737,3.5095297478903484,"['EGR2', 'RAB3A', 'RAB25', 'HSPB8', 'HSPB1', 'NEFL', 'MFN2', 'RABAC1', 'RAB11A', 'DNM2']",0.89787664951852,0,0,10
86,White fat cell differentiation WP4149,0.12957472652863916,1.7174132604562737,3.5095297478903484,"['CEBPA', 'CEBPB', 'EGR2', 'KLF5', 'DDIT3', 'EBF1', 'RORA', 'PPARG', 'KLF15', 'FOXO1']",0.89787664951852,0,0,10
87,DNA Mismatch Repair WP531,0.13405513972354766,1.766367986966704,3.549523664572569,"['POLE4', 'POLD4', 'POLD1', 'RPA3', 'POLE2', 'POLD2', 'POLE3', 'RPA2', 'POLE']",0.89787664951852,0,0,9
88,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.13542567408384334,1.460210366579386,2.9194457797653457,"['JUN', 'NFATC2', 'FOS', 'NFKBIA', 'ZAP70', 'CD4', 'IL5', 'RRAS', 'GRAP2', 'CHP1', 'LCP2', 'PTPN6', 'IKBKG', 'CALM1', 'MAP3K14', 'CALM2', 'MAPK3']",0.89787664951852,0,0,17
89,HIF1A and PPARG regulation of glycolysis WP2456,0.13863132057831845,2.746796392975795,5.4274972823617595,"['LDHA', 'TPI1', 'PPARG', 'GAPDH']",0.89787664951852,0,0,4
90,Irinotecan pathway WP229,0.13863132057831845,2.746796392975795,5.4274972823617595,"['ABCC1', 'ABCC2', 'CYP3A4', 'CYP3A5']",0.89787664951852,0,0,4
91,GDNF/RET signaling axis WP4830,0.1416799532367794,1.9231298978864877,3.7581508601922304,"['ROBO2', 'EYA1', 'GFRA1', 'SPRY1', 'FAT4', 'PAX2', 'GLI3']",0.89787664951852,0,0,7
92,Cells and molecules involved in local acute inflammatory response  WP4493,0.1437120058279924,2.2891447108157292,4.440812413017617,"['SELP', 'C3', 'SELPLG', 'C6', 'KNG1']",0.89787664951852,0,0,5
93,Farnesoid X receptor pathway WP2879,0.1437120058279924,2.2891447108157292,4.440812413017617,"['SLC10A1', 'ABCB4', 'CYP3A4', 'ABCB11', 'FKBP5']",0.89787664951852,0,0,5
94,Airway smooth muscle cell contraction WP4962,0.14390009741866097,2.060363247863248,3.994294340867187,"['RYR1', 'ROCK1', 'CD38', 'ITPR3', 'CALM1', 'CALM2']",0.89787664951852,0,0,6
95,miR-509-3p alteration of YAP1/ECM axis WP3967,0.14390009741866097,2.060363247863248,3.994294340867187,"['YAP1', 'COL1A1', 'EDNRA', 'SPARC', 'PBX3', 'FN1']",0.89787664951852,0,0,6
96,Phytochemical activity on NRF2 transcriptional activation WP3,0.14390009741866097,2.060363247863248,3.994294340867187,"['AIMP2', 'CEBPB', 'KEAP1', 'HMOX1', 'SLC7A11', 'EPHB2']",0.89787664951852,0,0,6
97,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.14723692671008387,1.3744341196092447,2.633020270607183,"['YAP1', 'ANGPT2', 'ANGPT1', 'BAD', 'TIE1', 'PXN', 'FN1', 'FOXO1', 'EGFR', 'NFKBIA', 'RAD51', 'MYC', 'STMN1', 'BAX', 'KRAS', 'NOS1', 'RAC1', 'IKBKG', 'HRAS', 'ANGPTL1', 'MAPK3']",0.9092259700962911,0,0,21
98,Base Excision Repair WP4752,0.15188315591573928,1.5908323220697334,2.9981522166730072,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'MPG', 'POLD1', 'APEX1', 'POLE2', 'POLD2', 'POLE3', 'POLE']",0.9283470448319167,0,0,11
99,Aryl Hydrocarbon Receptor Netpath WP2586,0.1563213626774526,1.479744565615165,2.746171187073427,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'LPL', 'EGFR', 'PSRC1', 'MYC', 'CDC37', 'E2F1', 'CYP1B1', 'AHRR', 'KRAS', 'HRAS']",0.9458231943817587,0,0,14
100,Oxidation by Cytochrome P450 WP43,0.16418085351401845,1.4884562029330162,2.689322861209133,"['CYP2J2', 'CYP3A43', 'CYP3A4', 'CYP2C19', 'CYP3A5', 'CYP2C18', 'CYP3A7', 'CYP27A1', 'CYP39A1', 'CYB5R1', 'CYP26B1', 'CYP2A6', 'CYP1B1']",0.9781675100632327,0,0,13
101,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.16609199225073726,1.6484675694939415,2.9593511921020874,"['ABCA1', 'ABCC3', 'ABCB1', 'ABCC2', 'ABCB4', 'NR1I3', 'PPARG', 'CYP3A4', 'ABCB11']",0.9781675100632327,0,0,9
102,DNA damage response WP707,0.16656608685550875,1.3423541732466713,2.4059861278802153,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'H2AFX', 'RPA2', 'CCNB2', 'CCND3', 'CASP8', 'RAD51', 'RRM2B', 'CCNE2', 'CDK5', 'MYC', 'SESN1', 'E2F1', 'ABL1', 'CDK1', 'CYCS', 'BAX', 'RAD9A']",0.9781675100632327,0,0,21
103,Tryptophan metabolism WP465,0.17255712274515733,1.4987679937751264,2.6333757583273765,"['CYP2J2', 'TPH1', 'WARS', 'HAAO', 'ALDH1A1', 'AOX1', 'CYP1B1', 'DHCR24', 'CYP3A4', 'CYP2C18', 'ACMSD', 'IDO1']",0.9885146821439368,0,0,12
104,Purinergic signaling WP4900,0.17350947158610583,1.6906267129545038,2.961171723990897,"['P2RY12', 'P2RX7', 'GNAZ', 'P2RY13', 'P2RY6', 'ADORA2A', 'LPAR6', 'P2RY14']",0.9885146821439368,0,0,8
105,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.17350947158610583,1.6906267129545038,2.961171723990897,"['GSK3A', 'BCL2L10', 'ITGB4', 'MYC', 'BCL2', 'BAX', 'BCL2L14', 'BCL2L2']",0.9885146821439368,0,0,8
106,G1 to S cell cycle control WP45,0.17492914241612237,1.340708118848697,2.337356061486559,"['CDKN2D', 'CDKN1A', 'CDKN2B', 'CDKN1B', 'CDKN2C', 'GADD45A', 'RPA2', 'CREB3', 'CCND3', 'CCNE2', 'TFDP2', 'MYC', 'CREB3L1', 'RPA3', 'POLE2', 'MCM3', 'E2F1', 'CDK1', 'MCM4', 'POLE']",0.9885146821439368,0,0,20
107,Metapathway biotransformation Phase I and II WP702,0.17721416936256373,1.225717027401642,2.1209761863445094,"['GAL3ST1', 'GSTP1', 'GLYAT', 'CYP2C19', 'CYP3A4', 'CYP2C18', 'CYP3A5', 'NAA80', 'CYP3A7', 'SULT1C2', 'CYP26B1', 'NDST4', 'CYP1B1', 'CHST13', 'GAL3ST2', 'SULT4A1', 'SULT1A2', 'SULT1C4', 'CYP2J2', 'CHST8', 'CHST9', 'GPX2', 'CHST6', 'GPX4', 'GPX3', 'GSTO1', 'CYP3A43', 'KCNAB1', 'HS3ST5', 'FMO5', 'HS3ST4', 'CYP27A1', 'CYP39A1', 'CYP2A6', 'CYP21A2', 'NAT8L', 'CHST2']",0.9920681069922961,0,0,37
108,Cholesterol Biosynthesis Pathway WP197,0.1882114143129666,1.831275720164609,3.0585773031828016,"['IDI1', 'SQLE', 'HMGCS1', 'PMVK', 'MSMO1', 'DHCR7']",0.9999954048088422,0,0,6
109,ERK Pathway in Huntington's Disease WP3853,0.1882114143129666,1.831275720164609,3.0585773031828016,"['RPS6KA5', 'BDNF', 'ELK1', 'HRAS', 'GRM1', 'EGFR']",0.9999954048088422,0,0,6
110,Synaptic Vesicle Pathway WP2267,0.18863415612111353,1.3739885768681581,2.291738505815965,"['NSF', 'RAB3A', 'CACNA1B', 'SLC1A3', 'CACNA1A', 'PARK7', 'SYP', 'SYN3', 'CPLX1', 'DNM2', 'CPLX3', 'CLTCL1', 'AP2S1', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.9999954048088422,0,0,16
111,Prostaglandin Synthesis and Regulation WP98,0.1917309137820212,1.4287942925089179,2.3598857826668036,"['EDN1', 'HPGD', 'PTGER2', 'PTGER3', 'MITF', 'PTGS1', 'HSD11B1', 'HSD11B2', 'EDNRA', 'S100A6', 'PPARG', 'PTGDS', 'PTGDR']",0.9999954048088422,0,0,13
112,RalA downstream regulated genes WP2290,0.19462692374585677,1.9619544945915703,3.2110735625873033,"['EXOC8', 'RAC3', 'KRAS', 'RAC1', 'HRAS']",0.9999954048088422,0,0,5
113,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.1971995769597875,2.74638196915777,4.458858186527557,"['TGFB1', 'IL5', 'CD80']",0.9999954048088422,0,0,3
114,Fatty Acid Omega Oxidation WP206,0.1971995769597875,2.74638196915777,4.458858186527557,"['CYP2A6', 'ALDH1A1', 'CYP3A4']",0.9999954048088422,0,0,3
115,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.1971995769597875,2.74638196915777,4.458858186527557,"['WNT6', 'CDKN1A', 'ABCB1']",0.9999954048088422,0,0,3
116,Bile acids synthesis and enterohepatic circulation  WP4389,0.19885871675705766,2.197247271001424,3.548907379764805,"['SLC10A1', 'FGFR4', 'ABCB11', 'MAPK3']",0.9999954048088422,0,0,4
117,Small Ligand GPCRs WP247,0.19885871675705766,2.197247271001424,3.548907379764805,"['PTGER2', 'PTGER3', 'S1PR2', 'PTGDR']",0.9999954048088422,0,0,4
118,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.19885871675705766,2.197247271001424,3.548907379764805,"['LFNG', 'NOTCH1', 'TBX6', 'DLL3']",0.9999954048088422,0,0,4
119,Bladder cancer WP2828,0.20221823296207253,1.4334801215654656,2.291285812547953,"['CDKN1A', 'RPS6KA5', 'CDH1', 'MYC', 'DAPK2', 'E2F1', 'KRAS', 'THBS1', 'HRAS', 'FGFR3', 'EGFR', 'TYMP']",0.9999954048088422,0,0,12
120,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.20221823296207253,1.4334801215654656,2.291285812547953,"['CREB3', 'STAR', 'CYP21A2', 'CREB3L1', 'HSD3B1', 'ITPR2', 'ITPR3', 'CALM3', 'REN', 'CALM1', 'CALM2', 'ATF4']",0.9999954048088422,0,0,12
121,Proteasome Degradation WP183,0.20681769754554383,1.305316742081448,2.0570715777355355,"['UBA7', 'H2AFZ', 'H2AFX', 'HLA-B', 'HLA-C', 'PSMB10', 'PSMA7', 'HLA-E', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'UBB', 'PSMC3', 'PSMD2', 'PSMC1', 'NEDD4', 'PSMD3', 'UBC']",0.9999954048088422,0,0,19
122,miRNA regulation of DNA damage response WP1530,0.2090143840514164,1.2824716067032007,2.0075197589071077,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'H2AFX', 'RPA2', 'CCNB2', 'CCND3', 'CASP8', 'RAD51', 'RRM2B', 'CCNE2', 'CDK5', 'MYC', 'SESN1', 'E2F1', 'ABL1', 'CDK1', 'CYCS', 'BAX', 'RAD9A']",0.9999954048088422,0,0,21
123,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.21233918871093088,1.5697319307770614,2.4324100355794642,"['ABCC3', 'JUN', 'ABCC2', 'SRXN1', 'GSTP1', 'KEAP1', 'HMOX1', 'FOS']",0.9999954048088422,0,0,8
124,CAMKK2  Pathway WP4874,0.21355480015237588,1.4390754637961674,2.2217336417178912,"['RPTOR', 'FIS1', 'MAP1LC3A', 'WFS1', 'HMOX1', 'NFATC2', 'NOS1', 'RAC1', 'CALM1', 'CALM2', 'MAPK3']",0.9999954048088422,0,0,11
125,Alzheimer's disease WP2059,0.22139259897522165,1.2444732366993279,1.8764387579934465,"['PSENEN', 'ATP5MD', 'MME', 'BAD', 'ITPR2', 'LPL', 'ITPR3', 'CACNA1C', 'RYR3', 'CASP8', 'PLCB4', 'PPP3R2', 'CDK5', 'CHP1', 'CYCS', 'CALM3', 'NOS1', 'CAPN1', 'FADD', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.9999954048088422,0,0,24
126,PPAR signaling pathway WP3942,0.22924239401098792,1.2975151418974318,1.9112078152083964,"['UCP1', 'APOA1', 'ACSL5', 'LPL', 'CPT1B', 'CYP27A1', 'CPT2', 'ACADL', 'ACOX2', 'FABP5', 'FABP6', 'FABP7', 'PPARG', 'ANGPTL4', 'PLIN1', 'ACSBG2', 'PCK2']",0.9999954048088422,0,0,17
127,MAPK pathway in congenital thyroid cancer WP4928,0.23693927427581477,1.648005698005698,2.373048107705486,"['JUN', 'MYC', 'KRAS', 'FOS', 'ELK1', 'MAPK3']",0.9999954048088422,0,0,6
128,NOTCH1 regulation of endothelial cell calcification WP3413,0.23693927427581477,1.648005698005698,2.373048107705486,"['NOTCH1', 'MGP', 'ALPL', 'PLAT', 'FGFR3', 'DLL3']",0.9999954048088422,0,0,6
129,Disruption of postsynaptic signaling by CNV WP4875,0.2477372262133737,1.3735440931780365,1.916625113168804,"['TJP1', 'NLGN1', 'ARC', 'DLG2', 'HOMER1', 'NRXN1', 'DLGAP1', 'GRM1', 'YWHAG', 'MAPK3', 'SHANK1']",0.9999954048088422,0,0,11
130,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.250615606247681,1.7165618324234513,2.375438279738341,"['STAG1', 'PTTG1', 'BUB1B', 'ANAPC11', 'MAD2L1']",0.9999954048088422,0,0,5
131,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.250615606247681,1.7165618324234513,2.375438279738341,"['JUN', 'IRAK1', 'TIFA', 'TLR9', 'TLR5']",0.9999954048088422,0,0,5
132,Gene regulatory network modelling somitogenesis  WP2854,0.2650867429101192,1.8308811896851764,2.4308576138590383,"['LFNG', 'NOTCH1', 'HES1', 'TBX6']",0.9999954048088422,0,0,4
133,Nanoparticle triggered regulated necrosis WP2513,0.2650867429101192,1.8308811896851764,2.4308576138590383,"['CASP8', 'TRADD', 'FADD', 'FTL']",0.9999954048088422,0,0,4
134,IL-5 signaling pathway WP127,0.26741175481859025,1.3185734664764621,1.739153116667761,"['GSK3A', 'SPRED1', 'JUN', 'STAT1', 'MYC', 'RPS6', 'BCL2', 'KRAS', 'FOS', 'JAK2', 'ELK1', 'MAPK3']",0.9999954048088422,0,0,12
135,Acute viral myocarditis WP4298,0.2690012811372682,1.2211105817585093,1.6033659842090064,"['EDN1', 'ENDOG', 'TGFB1', 'STAT1', 'CD80', 'ACTB', 'CD4', 'CASP8', 'CASP6', 'ABL1', 'BCL2', 'RAC3', 'CYCS', 'BAX', 'DMD', 'NOS1', 'TLR5', 'MICA', 'EIF4G2', 'MAPK3']",0.9999954048088422,0,0,20
136,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.26994889056739435,1.2363214285714286,1.618990891260787,"['GRIA1', 'CDKN1A', 'JUN', 'CDKN1B', 'FN1', 'ELK1', 'EGFR', 'SOD1', 'ACTA1', 'ERBB4', 'MYC', 'TMSB4X', 'NEFL', 'PFN4', 'NEFM', 'NOS1', 'NEFH', 'PFN2']",0.9999954048088422,0,0,18
137,Pathogenic Escherichia coli infection WP2272,0.27024138424426664,1.2558917522268307,1.6432586321105576,"['ROCK1', 'TUBB', 'ARPC5L', 'TUBB4B', 'ACTB', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1C', 'TUBB6', 'TUBA1A', 'TUBB2A', 'CDH1', 'TUBB3', 'ABL1', 'TLR5']",0.9999954048088422,0,0,16
138,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.2704900775309473,1.4789470799919624,1.933752683894864,"['H3F3B', 'H2AFJ', 'H2AFZ', 'H2AFX', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.9999954048088422,0,0,7
139,"Relationship between inflammation, COX-2 and EGFR WP4483",0.2704900775309473,1.4789470799919624,1.933752683894864,"['PTGES2', 'PTGER2', 'PTGER3', 'KRAS', 'HRAS', 'EGFR', 'MAPK3']",0.9999954048088422,0,0,7
140,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.27963534717612676,2.0596085409252667,2.624495019453289,"['CEBPB', 'ALDH1L1', 'ALDH1A1']",0.9999954048088422,0,0,3
141,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.27963534717612676,2.0596085409252667,2.624495019453289,"['HEY1', 'VEGFB', 'HES1']",0.9999954048088422,0,0,3
142,Nucleotide GPCRs WP80,0.27963534717612676,2.0596085409252667,2.624495019453289,"['P2RY6', 'ADORA2A', 'LPAR6']",0.9999954048088422,0,0,3
143,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.27963534717612676,2.0596085409252667,2.624495019453289,"['NFKBIA', 'MUC1', 'IKBKG']",0.9999954048088422,0,0,3
144,Parkinson's disease pathway WP2371,0.28369292462412465,1.3137111026136563,1.655095849441168,"['PINK1', 'UBA7', 'UBB', 'CCNE2', 'CASP6', 'SYT11', 'HTRA2', 'CYCS', 'UBE2L6', 'PARK7', 'SNCAIP']",0.9999954048088422,0,0,11
145,Cytosolic DNA-sensing pathway WP4655,0.2853017063947109,1.2486751887180152,1.566098460697205,"['IL33', 'CCL4L2', 'TRADD', 'IL18', 'ISG15', 'NFKBIA', 'CASP8', 'POLR1C', 'POLR2E', 'POLR3H', 'IKBKG', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999954048088422,0,0,15
146,BMP Signaling Pathway in Eyelid Development WP3927,0.28889889900107013,1.498057498057498,1.860105760916902,"['JUN', 'NOTCH1', 'DKK2', 'EGFR', 'MAPK3', 'FGF10']",0.9999954048088422,0,0,6
147,Matrix Metalloproteinases WP129,0.28889889900107013,1.498057498057498,1.860105760916902,"['MMP16', 'TIMP2', 'TIMP3', 'MMP19', 'MMP21', 'TIMP4']",0.9999954048088422,0,0,6
148,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.28889889900107013,1.498057498057498,1.860105760916902,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3CL', 'EIF3D', 'EIF1']",0.9999954048088422,0,0,6
149,Pyrimidine metabolism and related diseases WP4225,0.28889889900107013,1.498057498057498,1.860105760916902,"['NT5C', 'RRM2', 'RRM2B', 'DPYS', 'DPYD', 'TYMP']",0.9999954048088422,0,0,6
150,Effects of nitric oxide WP1995,0.29071759465624364,2.745967741935484,3.3923766438174385,"['AOX1', 'NOS1']",0.9999954048088422,0,0,2
151,Gastric acid production WP2596,0.29071759465624364,2.745967741935484,3.3923766438174385,"['CCK', 'MUC6']",0.9999954048088422,0,0,2
152,MED and Pseudoachondroplasia genes WP4789,0.29071759465624364,2.745967741935484,3.3923766438174385,"['COL9A3', 'COL9A2']",0.9999954048088422,0,0,2
153,Nanomaterial-induced inflammasome activation WP3890,0.29071759465624364,2.745967741935484,3.3923766438174385,"['NOX1', 'CTSB']",0.9999954048088422,0,0,2
154,Steroid Biosynthesis WP496,0.29071759465624364,2.745967741935484,3.3923766438174385,"['HSD17B1', 'HSD3B1']",0.9999954048088422,0,0,2
155,Sulindac Metabolic Pathway WP2542,0.29071759465624364,2.745967741935484,3.3923766438174385,"['MSRA', 'CYP1B1']",0.9999954048088422,0,0,2
156,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.2980900192831122,1.3732779097387173,1.6621603211923281,"['NFKBIA', 'ZAP70', 'GSK3A', 'CD8B', 'NFATC2', 'PTPN6', 'CALM1', 'CALM2']",0.9999954048088422,0,0,8
157,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.29989394531329416,1.2209001004812523,1.4703622013450215,"['CEBPA', 'CDKN1A', 'CEBPB', 'NOTCH1', 'TGFB1', 'ICMT', 'MSTN', 'TCF7', 'HMGA2', 'TNFRSF11B', 'ACTB', 'E2F1', 'PPARG', 'HES1', 'JUNB', 'HES5']",0.9999954048088422,0,0,16
158,miRNA regulation of prostate cancer signaling pathways WP3981,0.301597643803396,1.307939525620134,1.567776695095795,"['NFKBIA', 'CDKN1A', 'CDKN1B', 'BAD', 'CREB3L1', 'TCF7', 'BCL2', 'KRAS', 'IKBKG', 'FOXO1']",0.9999954048088422,0,0,10
159,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3023413695398871,1.2677493690332493,1.516479940864214,"['ACTA1', 'JUN', 'CASP8', 'CASP6', 'ARHGDIB', 'BCL2', 'HSPB1', 'CYCS', 'FADD', 'CFLAR', 'ACTB', 'ACTG1']",0.9999954048088422,0,0,12
160,TNF-alpha signaling pathway WP231,0.3092867377237433,1.1521254001477468,1.352003578689081,"['TRADD', 'TXN', 'CASP8', 'PSMD2', 'RFK', 'RAC1', 'IKBKG', 'FADD', 'HRAS', 'SKP1', 'MAPK3', 'HSP90AA1', 'JUN', 'BAD', 'CYBA', 'KSR2', 'CFLAR', 'TNFRSF1B', 'SELE', 'NFKBIA', 'CDC37', 'BAX', 'KRAS', 'NFKBIE', 'MAP3K14', 'NOX1']",0.9999954048088422,0,0,26
161,Fatty acid transporters WP5061,0.30990199189885426,1.5257008729593586,1.787357331751493,"['FABP5', 'FABP6', 'FABP7', 'ACSL5', 'ACSBG2']",0.9999954048088422,0,0,5
162,Calcium Regulation in the Cardiac Cell WP536,0.31185199842118344,1.1162882866714525,1.300728768901651,"['RYR1', 'GNAZ', 'CHRM1', 'RGS19', 'RGS14', 'YWHAB', 'CHRM5', 'CACNA1B', 'CACNA1A', 'ITPR2', 'ITPR3', 'ADRA1D', 'CACNA1C', 'ADRA1B', 'ADRA1A', 'RYR3', 'RGS4', 'GNG3', 'PLN', 'GRK5', 'RGS6', 'YWHAG', 'YWHAH', 'PRKCH', 'ATP1B1', 'GNG11', 'GJD2', 'FKBP1A', 'SLC8A3', 'ADCY9', 'PRKAR1A', 'FXYD2', 'GJB5', 'CALM3', 'PRKD1', 'CALR', 'CASQ1', 'CALM1', 'CALM2']",0.9999954048088422,0,0,39
163,Differentiation of white and brown adipocyte WP2895,0.31898037302409843,1.3731892662075516,1.5690413529324378,"['CEBPA', 'CEBPB', 'LEP', 'ZIC1', 'EBF3', 'PPARG', 'SLC7A10']",0.9999954048088422,0,0,7
164,Vitamin B12 metabolism WP1533,0.32103548598985665,1.2588641945963077,1.430326047066833,"['ABCA1', 'SERPINA3', 'CUBN', 'F7', 'TCN1', 'APOA1', 'PLAT', 'PLG', 'MPO', 'SOD3', 'SOD1']",0.9999954048088422,0,0,11
165,Endothelin Pathways WP2197,0.32143683410206225,1.3009716022057995,1.4765432192268053,"['CNN1', 'ADCY10', 'GNA15', 'EDNRA', 'EDN1', 'RIIAD1', 'CALM1', 'ADRA1A', 'CALM2']",0.9999954048088422,0,0,9
166,Modulators of TCR signaling and T cell activation WP5072,0.33044596271960663,1.18779988937057,1.3152652310514743,"['CDKN1B', 'NDUFB10', 'RHOH', 'RNF7', 'NFKBIA', 'ZAP70', 'FIBP', 'CD5', 'GRAP2', 'ELOB', 'LCP2', 'PTPN6', 'IKBKG', 'CD247', 'MEF2D', 'MAP3K14']",0.9999954048088422,0,0,16
167,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.33444372244731563,1.5691911316021425,1.718714109312128,"['ABCA1', 'LPL', 'APOA1', 'LDLRAP1']",0.9999954048088422,0,0,4
168,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.33444372244731563,1.5691911316021425,1.718714109312128,"['IDI1', 'HMGCS1', 'IDI2', 'PMVK']",0.9999954048088422,0,0,4
169,Sulfation Biotransformation Reaction WP692,0.33444372244731563,1.5691911316021425,1.718714109312128,"['SULT1C2', 'SULT4A1', 'SULT1C4', 'SULT1A2']",0.9999954048088422,0,0,4
170,Melanoma WP4685,0.3381543148501854,1.1597787833081952,1.257493549609341,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'MITF', 'FOS', 'ELK1', 'PREX2', 'CDH1', 'ERBB4', 'E2F1', 'BAX', 'KRAS', 'CALM3', 'RAC1', 'CALM1', 'HRAS', 'CALM2', 'MAPK3']",0.9999954048088422,0,0,19
171,Glycogen Synthesis and Degradation WP500,0.3383809544357546,1.2206900195487926,1.322718872950839,"['GYS2', 'GYS1', 'GSK3A', 'PHKG1', 'GBE1', 'PYGM', 'PHKA1', 'CALM3', 'CALM1', 'GYG1', 'CALM2', 'HK2']",0.9999954048088422,0,0,12
172,Methionine De Novo and Salvage Pathway WP3580,0.3428605221423973,1.3731006647673314,1.4698102804468007,"['MSRA', 'AHCY', 'CHDH', 'ODC1', 'TXN', 'MAT2B']",0.9999954048088422,0,0,6
173,Nucleotide metabolism WP404,0.3428605221423973,1.3731006647673314,1.4698102804468007,"['PRPS1', 'RRM2', 'RRM2B', 'POLD1', 'NME2', 'OAZ1']",0.9999954048088422,0,0,6
174,Transcription factor regulation in adipogenesis WP3599,0.3428605221423973,1.3731006647673314,1.4698102804468007,"['CEBPA', 'CEBPB', 'LEP', 'PPARG', 'FOXO1', 'PCK2']",0.9999954048088422,0,0,6
175,Cell migration and invasion through p75NTR WP4561,0.34362705244456015,1.292385077546458,1.3805236197999027,"['ARF1', 'JUN', 'EFNA3', 'EFNB3', 'BDNF', 'CDH11', 'RAC1', 'EFNA5']",0.9999954048088422,0,0,8
176,Glycosylation and related congenital defects WP4521,0.34362705244456015,1.292385077546458,1.3805236197999027,"['GMPPB', 'DPM2', 'DPM3', 'MPI', 'ALG3', 'DOLK', 'MGAT2', 'MPDU1']",0.9999954048088422,0,0,8
177,Photodynamic therapy-induced unfolded protein response WP3613,0.34362705244456015,1.292385077546458,1.3805236197999027,"['NARS', 'XBP1', 'WARS', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'ATF4']",0.9999954048088422,0,0,8
178,Glucocorticoid Receptor Pathway WP2880,0.35540826424316874,1.149767441860465,1.1894207480706152,"['HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'NR1I3', 'PLK2', 'AMIGO2', 'TGFBR3', 'THBD', 'ZIC2', 'NAV3', 'B3GNT5', 'ENC1', 'BHLHE40', 'SPINK13', 'SPRY1', 'ANGPTL4']",0.9999954048088422,0,0,18
179,Differentiation Pathway WP2848,0.35936124764301813,1.2084050392203471,1.2367145079228437,"['CNTF', 'TPO', 'LEFTY1', 'TF', 'NOTCH1', 'TGFB1', 'HGF', 'FGF1', 'DKK1', 'NODAL', 'FGF10']",0.9999954048088422,0,0,11
180,Prolactin Signaling Pathway WP2037,0.3600507084390083,1.1310039383873636,1.1553322862685969,"['JUN', 'CISH', 'STAT1', 'RPS6', 'PXN', 'FOS', 'ELK1', 'PRLR', 'NFKBIA', 'ZAP70', 'SOCS3', 'RPS6KA2', 'MYC', 'PTPN6', 'RAC1', 'JAK2', 'PPIB', 'CTSD', 'HRAS', 'YWHAG', 'MAPK3']",0.9999954048088422,0,0,21
181,Canonical NF-KB pathway WP4562,0.36423774129058323,1.6475444839857651,1.6639350623788762,"['NFKBIA', 'IKBKG', 'NFKBIE']",0.9999954048088422,0,0,3
182,Heart Development WP1591,0.3644439395564562,1.235816108339273,1.2474112027847275,"['TBX1', 'NOTCH1', 'HEY1', 'BHLHE40', 'VEGFB', 'NFATC3', 'SMYD1', 'NFATC2', 'FGF10']",0.9999954048088422,0,0,9
183,PKC-gamma calcium signaling pathway in ataxia WP4760,0.36874624708314846,1.2815324942610622,1.2785164700509333,"['GRIA1', 'GNA15', 'PLCB4', 'CACNA1A', 'CA8', 'RYR3', 'GRM1']",0.9999954048088422,0,0,7
184,Unfolded protein response WP4925,0.36874624708314846,1.2815324942610622,1.2785164700509333,"['XBP1', 'CASP8', 'HSPA5', 'DDIT3', 'BCL2', 'TXNIP', 'ATF4']",0.9999954048088422,0,0,7
185,Urea cycle and associated pathways WP4595,0.36874624708314846,1.2815324942610622,1.2785164700509333,"['SLC25A15', 'LDHB', 'OAT', 'GOT1', 'MDH2', 'PYCR1', 'NOS1']",0.9999954048088422,0,0,7
186,Dopaminergic Neurogenesis WP2855,0.3707472652261461,1.3730121053880846,1.3623502192271217,"['NR4A2', 'TGFB1', 'ALDH1A1', 'SLC18A2', 'GLI2']",0.9999954048088422,0,0,5
187,Hypertrophy Model WP516,0.3707472652261461,1.3730121053880846,1.3623502192271217,"['NR4A3', 'ZEB1', 'MSTN', 'WDR1', 'IL18']",0.9999954048088422,0,0,5
188,AGE/RAGE pathway WP2324,0.3737871054872292,1.1387880934272328,1.1206459240086903,"['MSR1', 'JUN', 'ROCK1', 'STAT1', 'MSN', 'FOXO4', 'FOXO1', 'EGFR', 'SOD1', 'NFKBIA', 'LGALS3', 'CASP8', 'ALPL', 'CYCS', 'RAC1', 'JAK2', 'MAPK3']",0.9999954048088422,0,0,17
189,DNA Replication WP466,0.37518050065114184,1.176992052170369,1.1538618440805737,"['POLD4', 'CDT1', 'POLD1', 'RPA3', 'POLE2', 'UBC', 'POLD2', 'MCM3', 'RPA2', 'MCM4', 'POLE', 'UBA52']",0.9999954048088422,0,0,12
190,Nephrotic syndrome WP4758,0.37518050065114184,1.176992052170369,1.1538618440805737,"['CUBN', 'TRPC6', 'ITGB4', 'LAMB2', 'ARHGDIA', 'PTPRO', 'COL4A3', 'PDSS2', 'GPC5', 'EMP2', 'ARHGAP24', 'PAX2']",0.9999954048088422,0,0,12
191,NO/cGMP/PKG mediated Neuroprotection WP4008,0.37518050065114184,1.176992052170369,1.1538618440805737,"['NFKBIA', 'BAD', 'NPPA', 'CNGA1', 'BCL2', 'PDE3A', 'NEFL', 'CYCS', 'NOS1', 'CALM1', 'CALM2', 'CNGB1']",0.9999954048088422,0,0,12
192,VEGFA-VEGFR2 Signaling Pathway WP3888,0.37596595291563284,1.0423647718497129,1.0197003119498116,"['RPL5', 'TRAF3IP2', 'NCF2', 'ARPC5L', 'RPL10A', 'ELK1', 'RPL7', 'ACTG1', 'TUBB8', 'RPS6KA5', 'RPL18A', 'CFL1', 'ATP6V1E1', 'EPHB2', 'RPS11', 'IER5', 'TMSB10', 'RPS6', 'SARS', 'DKK1', 'INPP4B', 'KATNAL2', 'TXNIP', 'PRKD2', 'RPL27', 'PRKD1', 'RPL26', 'ATP6V0D1', 'DSC1', 'ATF4', 'LRRC59', 'SET', 'NOTCH4', 'PXN', 'FOXO4', 'TXN', 'ACACB', 'FUT1', 'FOXO1', 'LDHA', 'PGK1', 'ABL1', 'IGFBP7', 'FADD', 'EGR1', 'JUN', 'SDF2L1', 'EGR3', 'FN1', 'NFATC2', 'BMX', 'SELE', 'QKI', 'NFKBIA', 'NR4A2', 'MOV10', 'NR4A1', 'NR4A3', 'P4HA2', 'BCL2', 'CYCS', 'HYOU1', 'CALR', 'EIF4G2', 'ARF4', 'FLT1', 'HSPB1', 'SHB', 'HERPUD1', 'RND1', 'TUBA1C', 'ADAMTS1', 'TMSB4X', 'RACK1', 'RPLP2', 'SH3BGRL3', 'ELOC', 'RAC1', 'ACP1', 'HRAS', 'PRKG1', 'DUSP5', 'HSP90AA1', 'SSR4', 'GAB1', 'RPL13A', 'EPN1', 'RCN1', 'TKT', 'ALDOA', 'GAPDH', 'SLC25A11', 'FJX1', 'ARF6', 'ROCK1', 'APOLD1', 'DNAJB4', 'AP2S1', 'DNAJB9', 'FLNB', 'CCT7', 'ABCF2', 'SLC25A25', 'MAPK3', 'STAT1', 'RAB11A', 'DNAJA1', 'PTPN9', 'PTPN6', 'EIF3D']",0.9999954048088422,0,0,110
193,Translation Factors WP107,0.3813309409357473,1.144321516377191,1.1032262638828803,"['EIF4A2', 'EIF2B2', 'EIF1AX', 'EEF2', 'GSPT2', 'EIF1', 'EEF1B2', 'EEF1G', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF3CL', 'EIF3D', 'EIF4B']",0.9999954048088422,0,0,15
194,Amyotrophic lateral sclerosis (ALS) WP2447,0.38243444170622765,1.1939990081005125,1.1476694999450996,"['GRIA1', 'BAD', 'BCL2', 'NEFL', 'BAX', 'NEFM', 'NOS1', 'RAC1', 'NEFH', 'SOD1']",0.9999954048088422,0,0,10
195,Androgen receptor signaling pathway WP138,0.38885496275976095,1.09861707200763,1.0376974933439562,"['CDKN1A', 'JUN', 'ROCK1', 'LIMK2', 'NCOA4', 'DSTN', 'RNF6', 'PARK7', 'ETV5', 'FOXO1', 'EGFR', 'RHOB', 'PSMC3IP', 'SUMO1', 'KAT5', 'PRDX1', 'BAG1', 'RACK1', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'RAN', 'RAD9A']",0.9999954048088422,0,0,24
196,16p11.2 distal deletion syndrome WP4950,0.3899907916621475,1.2204803378200053,1.1492435260718497,"['C3', 'PLN', 'SLN', 'CD81', 'MPL', 'NFATC2', 'JAK2', 'TUFM']",0.9999954048088422,0,0,8
197,Oxidative Stress WP408,0.3899907916621475,1.2204803378200053,1.1492435260718497,"['GPX3', 'HMOX1', 'FOS', 'JUNB', 'SOD3', 'NOX1', 'TXN2', 'SOD1']",0.9999954048088422,0,0,8
198,Ebstein-Barr virus LMP1 signaling WP262,0.3976321234660319,1.267367959675652,1.1688022365066852,"['NFKBIA', 'HSP90AA1', 'IRAK1', 'TRADD', 'IKBKG', 'MAP3K14']",0.9999954048088422,0,0,6
199,IL-4 signaling pathway WP395,0.4024300708289951,1.1307858062349583,1.0292796132466944,"['CEBPA', 'CEBPB', 'IL4R', 'STAT1', 'BAD', 'FOS', 'ELK1', 'NFKBIA', 'SOCS3', 'HRH1', 'FES', 'PTPN6', 'JAK2', 'MAPK3']",0.9999954048088422,0,0,14
200,Composition of Lipid Particles WP3601,0.4030415072191404,1.8304870335230867,1.663392354989286,"['APOA1', 'LPL']",0.9999954048088422,0,0,2
201,Hfe effect on hepcidin production WP3924,0.4030415072191404,1.8304870335230867,1.663392354989286,"['HJV', 'BMP6']",0.9999954048088422,0,0,2
202,let-7 inhibition of ES cell reprogramming WP3299,0.4030415072191404,1.8304870335230867,1.663392354989286,"['EGR1', 'MYC']",0.9999954048088422,0,0,2
203,Mitochondrial fatty acid synthesis pathway WP4317,0.4030415072191404,1.8304870335230867,1.663392354989286,"['HSD17B12', 'MCAT']",0.9999954048088422,0,0,2
204,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.4030415072191404,1.8304870335230867,1.663392354989286,"['MAS1', 'REN']",0.9999954048088422,0,0,2
205,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.4030415072191404,1.8304870335230867,1.663392354989286,"['FOXO1', 'IGF1R']",0.9999954048088422,0,0,2
206,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.4030415072191404,1.8304870335230867,1.663392354989286,"['EGFR', 'MAPK3']",0.9999954048088422,0,0,2
207,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4043520991980187,1.3729235880398671,1.243140088709557,"['GABBR1', 'GRM5', 'GRM4', 'GRM1']",0.9999954048088422,0,0,4
208,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.4043520991980187,1.3729235880398671,1.243140088709557,"['NFKBIA', 'RRAS', 'IKBKG', 'MAP3K14']",0.9999954048088422,0,0,4
209,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.4043520991980187,1.3729235880398671,1.243140088709557,"['JUN', 'ITPR3', 'RYR3', 'MAPK3']",0.9999954048088422,0,0,4
210,Osteoclast Signaling WP12,0.4043520991980187,1.3729235880398671,1.243140088709557,"['AIMP2', 'ATP6V1G1', 'GPR68', 'TNFRSF11B']",0.9999954048088422,0,0,4
211,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4043520991980187,1.3729235880398671,1.243140088709557,"['SELP', 'TGFB1', 'SELPLG', 'SELE']",0.9999954048088422,0,0,4
212,Serotonin and anxiety-related events WP3944,0.4043520991980187,1.3729235880398671,1.243140088709557,"['NLGN1', 'ARC', 'CRH', 'FOS']",0.9999954048088422,0,0,4
213,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4150580110531077,1.0984761904761904,0.9659307390663413,"['EGR1', 'JUN', 'CDKN1B', 'STAT1', 'KCNIP3', 'RPS6', 'FOS', 'TSHR', 'IGF1R', 'MYL12B', 'CCND3', 'MYC', 'APEX1', 'E2F1', 'JAK2', 'CGA', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,18
214,PI3K-Akt signaling pathway WP4172,0.41873479032811767,1.0370809037900874,0.9027970944435129,"['CDKN1A', 'CDKN1B', 'CHRM1', 'CSF3R', 'FLT1', 'ITGB4', 'FGF1', 'IGF1R', 'RPTOR', 'GYS2', 'GHR', 'GYS1', 'CCND3', 'MYC', 'CREB3L1', 'TNR', 'ITGB8', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'HSP90AA1', 'IL4R', 'HGF', 'RPS6', 'F2R', 'PRLR', 'CREB3', 'CCNE2', 'CDC37', 'COL4A3', 'ITGA8', 'COL6A6', 'ITGA5', 'COL6A5', 'SGK1', 'SGK2', 'ATF4', 'EFNA5', 'THBS1', 'EGFR', 'THBS4', 'GNG10', 'GNG3', 'PDGFC', 'EIF4B', 'PCK2', 'MAPK3', 'NTRK1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'BDNF', 'LAMB2', 'BAD', 'LAMB4', 'FN1', 'VEGFB', 'GNG11', 'COL1A1', 'FGF17', 'EFNA3', 'FGF14', 'LPAR6', 'IL7', 'ITGA10', 'ITGA11', 'BCL2', 'COL9A3', 'KRAS', 'COL9A2', 'FGFR4', 'FGFR3', 'FGF10']",0.9999954048088422,0,0,74
215,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.41890804137910237,1.201332818807884,1.0452843165381007,"['TGFBR3', 'POSTN', 'ANGPT2', 'LTBP2', 'LTBP1', 'MAPK3', 'TGFBR2']",0.9999954048088422,0,0,7
216,p38 MAPK Signaling Pathway WP400,0.42357672775490834,1.144150031685678,0.9828484535323975,"['RPS6KA5', 'STAT1', 'TRADD', 'MYC', 'DDIT3', 'HSPB1', 'RAC1', 'ELK1', 'HRAS', 'MEF2D']",0.9999954048088422,0,0,10
217,Gastrin signaling pathway WP4659,0.4289643915758414,1.0618795257420228,0.898755044394436,"['CDKN1A', 'CDKN1B', 'ROCK1', 'PXN', 'ELK1', 'FOXO1', 'EGFR', 'KAT5', 'CDH1', 'MYC', 'RAC1', 'JAK2', 'HRAS', 'MEF2D', 'MAPK3', 'EGR1', 'JUN', 'PRKCH', 'SERPINB2', 'BAD', 'RPS6', 'FOS', 'RHOB', 'NFKBIA', 'TJP1', 'PRKD2', 'PPARG', 'KRAS', 'PRKD1']",0.9999954048088422,0,0,29
218,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.431569057311795,1.2480849319206784,1.048800391596359,"['RAB27A', 'SYTL5', 'SYTL4', 'SYTL3', 'UNC13D']",0.9999954048088422,0,0,5
219,Pathways in clear cell renal cell carcinoma WP4018,0.43245407825913385,1.0705238278014586,0.8973977890974149,"['FLT1', 'TPI1', 'TGFB1', 'BHLHE41', 'ENO1', 'ENO2', 'SDSL', 'ACACB', 'HK2', 'EGFR', 'RPTOR', 'LDHC', 'ACLY', 'LDHB', 'LDHA', 'PKM', 'ZEB1', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'PFKM']",0.9999954048088422,0,0,23
220,Retinoblastoma gene in cancer WP2446,0.43245407825913385,1.0705238278014586,0.8973977890974149,"['PLK4', 'CDT1', 'CDKN1A', 'CDKN1B', 'RRM2', 'H2AFZ', 'SUV39H1', 'RPA2', 'CCNB2', 'CCND3', 'CCNE2', 'TFDP2', 'MYC', 'RPA3', 'POLE2', 'STMN1', 'MCM3', 'E2F1', 'ABL1', 'CDK1', 'MCM4', 'SKP2', 'POLE']",0.9999954048088422,0,0,23
221,IL17 signaling pathway WP2112,0.43649951076552823,1.156144518064758,0.9584068371942037,"['CEBPB', 'TRAF3IP2', 'IKBKG', 'IL17RE', 'JAK2', 'IL17RD', 'MAP3K14', 'MAPK3']",0.9999954048088422,0,0,8
222,ATM Signaling Pathway WP2516,0.43734209382855915,1.118699874107528,0.9252090591790609,"['NFKBIA', 'CDKN1A', 'JUN', 'RAD51', 'CRADD', 'GADD45A', 'H2AFX', 'ABL1', 'CDK1', 'IKBKG', 'RAD9A']",0.9999954048088422,0,0,11
223,Hematopoietic Stem Cell Differentiation WP2849,0.43734209382855915,1.118699874107528,0.9252090591790609,"['HES6', 'MUC1', 'TPO', 'TRAF3IP3', 'NOTCH1', 'IL5', 'RHOH', 'NFATC2', 'FOS', 'ABO', 'RUNX1']",0.9999954048088422,0,0,11
224,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.43734209382855915,1.118699874107528,0.9252090591790609,"['NFKBIA', 'HCK', 'CISH', 'STAT1', 'FES', 'MYC', 'TNFSF4', 'RPS6', 'JAK2', 'RELB', 'MAPK3']",0.9999954048088422,0,0,11
225,Vitamin A and carotenoid metabolism WP716,0.43734209382855915,1.118699874107528,0.9252090591790609,"['ALDH1A3', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'NPC1L1', 'ALDH1A1', 'LPL', 'LRAT', 'BCO1', 'RLBP1']",0.9999954048088422,0,0,11
226,"Degradation pathway of sphingolipids, including diseases WP4153",0.44692721892664683,1.372835112692764,1.10562582577547,"['GM2A', 'NEU1', 'GLA']",0.9999954048088422,0,0,3
227,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.44692721892664683,1.372835112692764,1.10562582577547,"['STAT1', 'BLVRB', 'HMOX1']",0.9999954048088422,0,0,3
228,PTF1A related regulatory pathway WP4147,0.44692721892664683,1.372835112692764,1.10562582577547,"['NOTCH1', 'HES1', 'FGF10']",0.9999954048088422,0,0,3
229,Supression of HMGB1 mediated inflammation by THBD WP4479,0.44692721892664683,1.372835112692764,1.10562582577547,"['NFKBIA', 'THBD', 'IKBKG']",0.9999954048088422,0,0,3
230,Trans-sulfuration pathway WP2333,0.44692721892664683,1.372835112692764,1.10562582577547,"['AHCY', 'GOT1', 'MAT2B']",0.9999954048088422,0,0,3
231,One-carbon metabolism WP241,0.45212155068795773,1.1767399267399268,0.9341011171592288,"['ALDH1L1', 'AHCY', 'CHDH', 'DNMT3A', 'GLRX', 'MAT2B']",0.9999954048088422,0,0,6
232,Urea cycle and metabolism of amino groups WP497,0.45212155068795773,1.1767399267399268,0.9341011171592288,"['OAT', 'CKM', 'ODC1', 'PYCR1', 'PYCR3', 'CKB']",0.9999954048088422,0,0,6
233,Arylamine metabolism WP694,0.4627416421459707,2.7455537111690775,2.1156863199979323,['SULT1A2'],0.9999954048088422,0,0,1
234,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.4627416421459707,2.7455537111690775,2.1156863199979323,['FMO5'],0.9999954048088422,0,0,1
235,"COVID-19, thrombosis and anticoagulation WP4927",0.4627416421459707,2.7455537111690775,2.1156863199979323,['PLG'],0.9999954048088422,0,0,1
236,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.46459320930989617,1.0982889733840304,0.8419407213015208,"['IFITM3', 'BST2', 'JUN', 'IFITM2', 'RPS6KA2', 'DDIT3', 'BCL2', 'FOS', 'JUNB', 'MAPK3']",0.9999954048088422,0,0,10
237,Cell cycle WP179,0.4656621572303362,1.038076625093932,0.7933966623432235,"['ANAPC13', 'CDKN1A', 'CDKN1B', 'YWHAB', 'CDC14A', 'CDC14B', 'ANAPC11', 'CCNB2', 'CCND3', 'PTTG1', 'PTTG2', 'MYC', 'ABL1', 'E2F1', 'SKP2', 'YWHAG', 'SKP1', 'YWHAH', 'CDKN2D', 'CDKN2B', 'TGFB1', 'CDKN2C', 'GADD45B', 'GADD45A', 'STAG1', 'RBL1', 'CCNE2', 'TFDP2', 'CDK1', 'MCM3', 'MCM4']",0.9999954048088422,0,0,31
238,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.46813817392563084,1.033394255807557,0.7843377489737494,"['TPH1', 'CEBPB', 'YWHAB', 'CDCA7L', 'SLC1A3', 'ATP1A3', 'RORA', 'FOXM1', 'HES1', 'PKNOX1', 'YWHAG', 'HES5', 'YWHAH', 'NKX3-1', 'CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'CAV3', 'BDNF', 'SSTR1', 'POU2F2', 'GCK', 'ADCYAP1', 'TF', 'REST', 'PRKAR1A', 'KCNQ1', 'BHLHE40', 'CHRFAM7A', 'AVP', 'ALDOA', 'GAPDH', 'SCN4B', 'SLC25A4']",0.9999954048088422,0,0,35
239,Gastric Cancer Network 1 WP2361,0.46865661872457187,1.130568399290374,0.8568407577309123,"['SMOC2', 'NOTCH1', 'ACTL6A', 'MCM4', 'GATD3B', 'LIN9', 'GATD3A']",0.9999954048088422,0,0,7
240,Allograft Rejection WP2328,0.47104292217076327,1.0677793635690875,0.8038307748300435,"['ABCB1', 'TGFB1', 'STAT1', 'CD80', 'HLA-B', 'HLA-C', 'HLA-E', 'C3', 'CASP8', 'C6', 'IL5', 'C9', 'MICA', 'HLA-DRB1']",0.9999954048088422,0,0,14
241,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.47267939890048344,1.2202710541580974,0.9143953783131741,"['POSTN', 'NOTCH1', 'EPAS1', 'TCF7']",0.9999954048088422,0,0,4
242,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.47267939890048344,1.2202710541580974,0.9143953783131741,"['RYR1', 'CD38', 'CCK', 'RYR3']",0.9999954048088422,0,0,4
243,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.47267939890048344,1.2202710541580974,0.9143953783131741,"['CDH1', 'E2F1', 'TULP3', 'SOX4']",0.9999954048088422,0,0,4
244,Homologous recombination WP186,0.47267939890048344,1.2202710541580974,0.9143953783131741,"['POLD4', 'RAD51', 'POLD1', 'POLD2']",0.9999954048088422,0,0,4
245,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.48252456233732266,1.0982422802850356,0.8003149068299344,"['EDA', 'SMO', 'CDH1', 'MYC', 'PTCH1', 'FGF1', 'TP63', 'GLI2']",0.9999954048088422,0,0,8
246,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.48252456233732266,1.0982422802850356,0.8003149068299344,"['RPTOR', 'CDKN1B', 'BAD', 'TFEB', 'KRAS', 'FOXO4', 'HRAS', 'FOXO1']",0.9999954048088422,0,0,8
247,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.48252456233732266,1.0982422802850356,0.8003149068299344,"['COL1A1', 'ADAMTS2', 'P4HA1', 'P4HA2', 'CREB3L1', 'SERPINF1', 'TNFRSF11B', 'PPIB']",0.9999954048088422,0,0,8
248,Apoptosis WP254,0.4832930785698414,1.0433484162895927,0.7586520429837226,"['JUN', 'CRADD', 'BAD', 'TRADD', 'CFLAR', 'TNFRSF1B', 'IGF1R', 'NFKBIA', 'CASP8', 'CASP6', 'MYC', 'BCL2', 'CYCS', 'BAX', 'IKBKG', 'FADD', 'NFKBIE', 'TP63', 'BCL2L2']",0.9999954048088422,0,0,19
249,TGF-beta Receptor Signaling WP560,0.4866896604078291,1.0628134922461001,0.7653623993006858,"['TGFBR3', 'FKBP1A', 'LEFTY1', 'JUN', 'TGFB1', 'STAT1', 'FOS', 'HRAS', 'LTBP1', 'THBS1', 'TGFBR2', 'MAPK3']",0.9999954048088422,0,0,12
250,Oncostatin M Signaling Pathway WP2374,0.48919391313446975,1.0459418417533601,0.7478445654189796,"['EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'STAT1', 'RPS6', 'PXN', 'FOS', 'NFKBIA', 'SOCS3', 'TIMP3', 'KRAS', 'JAK2', 'JUNB', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,16
251,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.49101492905014754,1.1439789540311733,0.8136902041203352,"['CDKN1A', 'ENPP1', 'ALPL', 'ROS1', 'FGFR3']",0.9999954048088422,0,0,5
252,"GPCRs, Class B Secretin-like WP334",0.49101492905014754,1.1439789540311733,0.8136902041203352,"['ADGRE2', 'ADGRG2', 'PTH1R', 'ADGRL2', 'ADGRL3']",0.9999954048088422,0,0,5
253,Proteoglycan biosynthesis WP4784,0.49101492905014754,1.1439789540311733,0.8136902041203352,"['EXT1', 'B3GAT3', 'XYLT1', 'B3GALT6', 'B4GALT7']",0.9999954048088422,0,0,5
254,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.49622447921165813,1.049765685108764,0.7355990286220425,"['LEFTY1', 'JUN', 'TGFB1', 'STAT1', 'FOS', 'LTBP1', 'THBS1', 'ADAMTS10', 'TGFBR2', 'TGFBR3', 'FKBP1A', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,13
255,TYROBP causal network in microglia WP3945,0.49622447921165813,1.049765685108764,0.7355990286220425,"['IGSF6', 'NCF2', 'IL18', 'LHFPL2', 'TNFRSF1B', 'SAMSN1', 'ZFP36L2', 'C3', 'CD4', 'ADAP2', 'DPYD', 'SFT2D2', 'TMEM106A']",0.9999954048088422,0,0,13
256,Endometrial cancer WP4155,0.4973515413206984,1.0372027824063055,0.724442763875682,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'TCF7', 'FOS', 'FGF1', 'ELK1', 'EGFR', 'CDH1', 'MYC', 'BAX', 'KRAS', 'CTNNA2', 'HRAS', 'FGFR3', 'MAPK3']",0.9999954048088422,0,0,17
257,Phosphodiesterases in neuronal function WP4222,0.5049879825491053,1.0388304574793632,0.7097504172017366,"['GRIA1', 'PDE6H', 'ADCY10', 'ADCY9', 'PDE10A', 'ADORA2A', 'PDE3A', 'PDE6C', 'PDE5A', 'CHRFAM7A', 'NOS1', 'PDE6A', 'DRD2', 'PDE9A']",0.9999954048088422,0,0,14
258,IL-2 signaling pathway WP49,0.5050670232240508,1.055955688797894,0.7212854636629548,"['SOCS3', 'JUN', 'CISH', 'STAT1', 'MYC', 'RPS6', 'BCL2', 'FOS', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,10
259,IL-7 signaling pathway WP205,0.5053779964567464,1.098195631528965,0.7494620952739156,"['CDKN1B', 'STAT1', 'BAD', 'IL7', 'MYC', 'MAPK3']",0.9999954048088422,0,0,6
260,Statin inhibition of cholesterol production WP430,0.5053779964567464,1.098195631528965,0.7494620952739156,"['ABCA1', 'SQLE', 'APOC1', 'LPL', 'APOA1', 'ACSS1']",0.9999954048088422,0,0,6
261,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.5059624136099278,1.372746679316888,0.9352425576843574,"['PPARG', 'CYP2C18']",0.9999954048088422,0,0,2
262,FTO Obesity Variant Mechanism WP3407,0.5059624136099278,1.372746679316888,0.9352425576843574,"['TBX1', 'UCP1']",0.9999954048088422,0,0,2
263,Metabolism of alpha-linolenic acid WP4586,0.5059624136099278,1.372746679316888,0.9352425576843574,"['ALOX15', 'ALOX12']",0.9999954048088422,0,0,2
264,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.5059624136099278,1.372746679316888,0.9352425576843574,"['SIX4', 'STRADB']",0.9999954048088422,0,0,2
265,Peroxiredoxin 2 induced ovarian failure WP4873,0.5059624136099278,1.372746679316888,0.9352425576843574,"['STAR', 'BAX']",0.9999954048088422,0,0,2
266,Somatic sex determination WP4814,0.5059624136099278,1.372746679316888,0.9352425576843574,"['PTGDS', 'AMH']",0.9999954048088422,0,0,2
267,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5122207133027575,1.0228018809333688,0.6842541168940427,"['CDKN1A', 'JUN', 'TGFB1', 'GADD45B', 'DCC', 'BAD', 'GADD45A', 'TCF7', 'FOS', 'NTN1', 'TGFBR2', 'MYC', 'BCL2', 'RAC3', 'CYCS', 'BAX', 'KRAS', 'RAC1', 'MAPK3']",0.9999954048088422,0,0,19
268,Head and Neck Squamous Cell Carcinoma WP4674,0.5122207133027575,1.0228018809333688,0.6842541168940427,"['CDKN1A', 'NOTCH1', 'MAML1', 'RPS6', 'GAB1', 'KEAP1', 'EGFR', 'IGF1R', 'TGFBR2', 'RPTOR', 'FKBP1A', 'CASP8', 'SESN1', 'E2F1', 'KRAS', 'FADD', 'HRAS', 'FGFR3', 'TP63']",0.9999954048088422,0,0,19
269,Hippo-Merlin Signaling Dysregulation WP4541,0.5170470518268548,1.0114432860193443,0.6671696356149543,"['FLT1', 'ITGB4', 'FOXM1', 'EGFR', 'IGF1R', 'PPP1CC', 'CDH4', 'CDH3', 'CDH1', 'CDH20', 'MYC', 'ITGB8', 'HRAS', 'NTRK1', 'PLCB4', 'PRKAR1A', 'ITGA10', 'ITGA11', 'CDH11', 'CDH12', 'ITGA8', 'KRAS', 'ITGA5', 'FGFR4', 'FGFR3', 'CDH17', 'CDH18', 'CDH19']",0.9999954048088422,0,0,28
270,Striated Muscle Contraction Pathway WP383,0.5172792043273085,1.067666693052587,0.7037765266340735,"['ACTA2', 'MYOM1', 'ACTA1', 'ACTC1', 'DMD', 'NEB', 'ACTG1']",0.9999954048088422,0,0,7
271,Nucleotide Excision Repair WP4753,0.5231564142231666,1.0295114122681883,0.6669944884380198,"['POLE4', 'POLD4', 'CETN2', 'POLD1', 'RPA3', 'POLE2', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'POLE', 'GTF2H5']",0.9999954048088422,0,0,12
272,Neuroinflammation WP4919,0.5248588074766064,1.176614133197763,0.7584760512850033,"['NFKBIA', 'JUN', 'FOS']",0.9999954048088422,0,0,3
273,7q11.23 copy number variation syndrome WP4932,0.5296580817704161,1.0052951295559618,0.6388887892035313,"['ATP5MC2', 'ATP5MC3', 'UBE2L6', 'ACACB', 'ATP5MC1', 'GRIP1', 'ATP5F1B', 'MYC', 'CFL1', 'BCL7B', 'EIF4H', 'PRKG1', 'MAPK3', 'ATP5PB', 'H2AFX', 'HMGA1', 'NRG1', 'ATP5F1D', 'ATP5F1E', 'USF1', 'CLDN5', 'CLDN4', 'ATP5PO', 'GTF2IRD1', 'GAPDH', 'ATF4']",0.9999954048088422,0,0,26
274,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5365250223070129,1.0294903777619386,0.641004028191336,"['LDHA', 'EDN1', 'ANGPT2', 'PKM', 'ANGPT1', 'IGFBP2', 'PGK1', 'BAX', 'SLC2A3']",0.9999954048088422,0,0,9
275,Pre-implantation embryo WP3527,0.5365250223070129,1.0294903777619386,0.641004028191336,"['EGR1', 'ZFP36', 'ARGFX', 'CDH1', 'DDIT3', 'HMGA1', 'ATP1A1', 'AQP3', 'ZFP36L2']",0.9999954048088422,0,0,9
276,Type 2 papillary renal cell carcinoma WP4241,0.5365250223070129,1.0294903777619386,0.641004028191336,"['CDKN1A', 'TGFB1', 'EGLN2', 'EPAS1', 'CADM2', 'TFEB', 'COL21A1', 'ELOB', 'ELOC']",0.9999954048088422,0,0,9
277,ID signaling pathway WP53,0.5377903247686049,1.0981490270526815,0.6811670446897581,"['RBL1', 'ID3', 'ELK1', 'PAX2']",0.9999954048088422,0,0,4
278,Leptin Insulin Overlap WP3935,0.5377903247686049,1.0981490270526815,0.6811670446897581,"['SOCS3', 'LEP', 'LEPR', 'JAK2']",0.9999954048088422,0,0,4
279,Vitamin D-sensitive calcium signaling in depression WP4698,0.5446240693139398,1.0167582030699902,0.6178427847580853,"['CYP27A1', 'TPH1', 'GRM5', 'CHRM1', 'CALB1', 'GPX4', 'BCL2', 'ITPR2', 'ITPR3', 'CACNA1C']",0.9999954048088422,0,0,10
280,IL1 and megakaryocytes in obesity WP2865,0.5479973608836536,1.0558892804323614,0.6351013610588638,"['SELENBP1', 'IRAK1', 'F2R', 'IL18', 'TIMP2']",0.9999954048088422,0,0,5
281,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5479973608836536,1.0558892804323614,0.6351013610588638,"['RRAS', 'RAB27A', 'KRAS', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,5
282,Nicotine Activity on Dopaminergic Neurons WP1602,0.5479973608836536,1.0558892804323614,0.6351013610588638,"['CHRNB2', 'CDK5', 'DRD2', 'DRD3', 'SLC18A2']",0.9999954048088422,0,0,5
283,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.5479973608836536,1.0558892804323614,0.6351013610588638,"['TGFB1', 'SUV39H1', 'CDC37', 'FN1', 'IGFBP7']",0.9999954048088422,0,0,5
284,IL-6 signaling pathway WP364,0.5520017199949259,1.0065684177165042,0.5981070976249176,"['SOCS3', 'HCK', 'STAT1', 'BAD', 'GAB1', 'PRDM1', 'RAC1', 'JAK2', 'JUNB', 'MAPK3', 'NR2F6']",0.9999954048088422,0,0,11
285,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.5566148733921201,1.0294693732193732,0.6031472751052812,"['HPGD', 'TRPA1', 'ACOX2', 'ALOX15', 'ALOX12', 'TRPV1']",0.9999954048088422,0,0,6
286,Estrogen signaling pathway WP712,0.5566148733921201,1.0294693732193732,0.6031472751052812,"['JUN', 'GPER1', 'BCL2', 'FOS', 'IKBKG', 'ELK1']",0.9999954048088422,0,0,6
287,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5566148733921201,1.0294693732193732,0.6031472751052812,"['BDNF', 'RPS6', 'CGA', 'SGK1', 'FOXO1', 'MAPK3']",0.9999954048088422,0,0,6
288,NRF2-ARE regulation WP4357,0.5566148733921201,1.0294693732193732,0.6031472751052812,"['AIMP2', 'CEBPB', 'KEAP1', 'HMOX1', 'SLC7A11', 'EPHB2']",0.9999954048088422,0,0,6
289,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5641749087292606,1.0113862190503569,0.5789083224828198,"['CEBPA', 'CEBPB', 'ERBB4', 'MYC', 'JAK2', 'PRLR', 'EGFR']",0.9999954048088422,0,0,7
290,Toll-like Receptor Signaling related to MyD88 WP3858,0.5641749087292606,1.0113862190503569,0.5789083224828198,"['TICAM2', 'IRAK1', 'TOLLIP', 'TLR9', 'IKBKG', 'TLR5', 'RELB']",0.9999954048088422,0,0,7
291,Leptin signaling pathway WP2034,0.5687930319181288,0.9840348330914369,0.5552304868232035,"['GSK3A', 'CISH', 'ROCK1', 'STAT1', 'BAD', 'RPS6', 'ELK1', 'ACACB', 'FOXO1', 'SOCS3', 'CFL2', 'LEP', 'LEPR', 'BAX', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,19
292,Fluoropyrimidine Activity WP1601,0.5709717140568181,0.9982293241200605,0.559423293706869,"['ABCC3', 'CYP2A6', 'RRM2', 'DPYS', 'DPYD', 'UPP2', 'TK1', 'TYMP']",0.9999954048088422,0,0,8
293,GABA receptor Signaling WP4159,0.5709717140568181,0.9982293241200605,0.559423293706869,"['GABRA1', 'GABRB1', 'GABBR1', 'AP2S1', 'GABRE', 'GABRD', 'GABRG3', 'AP2M1']",0.9999954048088422,0,0,8
294,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5709717140568181,0.9982293241200605,0.559423293706869,"['YAP1', 'LPL', 'FOXO6', 'FOXO4', 'PRDM1', 'RAC1', 'FOXO1', 'FERMT3']",0.9999954048088422,0,0,8
295,Prion disease pathway WP3995,0.5709717140568181,0.9982293241200605,0.559423293706869,"['PRNP', 'HSPA5', 'RFX5', 'EBF1', 'BCL2', 'POU2F2', 'ELK1', 'MAPK3']",0.9999954048088422,0,0,8
296,3q29 copy number variation syndrome WP4906,0.5765829596991595,0.980337174127324,0.539808986568715,"['GRIA1', 'TM4SF19', 'JUN', 'TGFB1', 'NCBP2', 'DYNLT3', 'PXN', 'MAD2L1BP', 'FBXO45', 'SLC51A', 'DYNLL1', 'DYNLL2', 'PIGX', 'TF', 'MYC']",0.9999954048088422,0,0,15
297,Notch Signaling Pathway Netpath WP61,0.5765829596991595,0.980337174127324,0.539808986568715,"['PSENEN', 'HES6', 'NOTCH3', 'CDKN1A', 'NOTCH1', 'MAML2', 'MAML1', 'NOTCH4', 'DLL3', 'HEY1', 'MYC', 'HES1', 'JAK2', 'HES5', 'SKP1']",0.9999954048088422,0,0,15
298,Integrated Cancer Pathway WP1971,0.5883138707824054,0.9740141239255619,0.5167093106495239,"['CDKN1A', 'CDKN2B', 'CDKN1B', 'CASP8', 'STAT1', 'BAD', 'MYC', 'E2F1', 'BCL2', 'CDK1', 'BAX']",0.9999954048088422,0,0,11
299,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5933724561529542,0.9687840899555257,0.5056403759612909,"['PPP1R3G', 'PPP1CC', 'PPP1R3F', 'PPP1R14B', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'PPP1R1C', 'DDIT3', 'BCL2', 'ATF4']",0.9999954048088422,0,0,12
300,Biomarkers for urea cycle disorders WP4583,0.5962644133083466,1.0294483985765124,0.5322979785876879,"['F7', 'F10', 'GOT1']",0.9999954048088422,0,0,3
301,"NAD metabolism, sirtuins and aging WP3630",0.5962644133083466,1.0294483985765124,0.5322979785876879,"['PPARG', 'ROS1', 'FOXO1']",0.9999954048088422,0,0,3
302,Osteoblast Signaling WP322,0.5962644133083466,1.0294483985765124,0.5322979785876879,"['COL1A1', 'TNFRSF11B', 'PTH1R']",0.9999954048088422,0,0,3
303,Benzo(a)pyrene metabolism WP696,0.5964931719875253,1.098102466793169,0.5673758010747598,"['CYP1B1', 'CYP3A4']",0.9999954048088422,0,0,2
304,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.5964931719875253,1.098102466793169,0.5673758010747598,"['DHCR24', 'DHCR7']",0.9999954048088422,0,0,2
305,LDLRAD4 and what we know about it WP4904,0.5964931719875253,1.098102466793169,0.5673758010747598,"['NEDD4', 'TGFBR2']",0.9999954048088422,0,0,2
306,Mevalonate pathway WP3963,0.5964931719875253,1.098102466793169,0.5673758010747598,"['HMGCS1', 'PMVK']",0.9999954048088422,0,0,2
307,Tgif disruption of Shh signaling WP3674,0.5964931719875253,1.098102466793169,0.5673758010747598,"['NODAL', 'GLI3']",0.9999954048088422,0,0,2
308,Tryptophan catabolism leading to NAD+ production WP4210,0.5985332133986939,0.9982310048755232,0.5123652832269238,"['HAAO', 'NMNAT3', 'KMO', 'IDO1']",0.9999954048088422,0,0,4
309,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.601699195008095,0.980383845919094,0.4980326747458626,"['LDHA', 'RPS6', 'KEAP1', 'PDHB', 'ACACB']",0.9999954048088422,0,0,5
310,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.601699195008095,0.980383845919094,0.4980326747458626,"['CASP8', 'BAD', 'BCL2', 'BAX', 'FADD']",0.9999954048088422,0,0,5
311,miRNA targets in ECM and membrane receptors WP2911,0.601699195008095,0.980383845919094,0.4980326747458626,"['LAMB2', 'COL5A3', 'ITGA11', 'FN1', 'THBS1']",0.9999954048088422,0,0,5
312,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.601699195008095,0.980383845919094,0.4980326747458626,"['HTR2B', 'KRAS', 'ELK1', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,5
313,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.601699195008095,0.980383845919094,0.4980326747458626,"['EGR1', 'HTR7', 'RPS6KA5', 'ELK1', 'MAPK3']",0.9999954048088422,0,0,5
314,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6047771532969752,0.9606028115320467,0.48308257228942836,"['KLB', 'NOTCH1', 'BAD', 'RPS6', 'DIO1', 'DIO2', 'UCP1', 'ITPR2', 'FOXO1', 'TSHR', 'RPTOR', 'MC4R', 'POMC', 'CREB3', 'TPO', 'TG', 'NPPA', 'ZNF516', 'PPARG', 'PLIN1', 'HRAS']",0.9999954048088422,0,0,21
315,Pathways Regulating Hippo Signaling WP4540,0.6088376314183629,0.9584033168399231,0.4755632353901411,"['NTRK1', 'PRKCH', 'FLT1', 'TCF7', 'PRKAG2', 'EGFR', 'IGF1R', 'CDH4', 'CDH3', 'PLCB4', 'CDH1', 'PRKD3', 'PRKAR1A', 'CDH20', 'CDH11', 'CDH12', 'RAC1', 'FGFR4', 'FGFR3', 'CDH17', 'CDH18', 'CDH19']",0.9999954048088422,0,0,22
316,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6088612686216568,0.9607337924483496,0.47668232760371776,"['TGFBR3', 'TGFB1', 'HGF', 'KRAS', 'HRAS', 'EGFR', 'TGFBR2']",0.9999954048088422,0,0,7
317,Type II interferon signaling (IFNG) WP619,0.6088612686216568,0.9607337924483496,0.47668232760371776,"['SOCS3', 'STAT1', 'HLA-B', 'TAP1', 'ISG15', 'JAK2', 'GBP1']",0.9999954048088422,0,0,7
318,Cardiac Progenitor Differentiation WP2406,0.612526391020149,0.9547454301352887,0.46798112306436246,"['MESP1', 'NOTCH1', 'TGFB1', 'ACTC1', 'NRG1', 'THY1', 'DKK1', 'NODAL']",0.9999954048088422,0,0,8
319,Neovascularisation processes WP4331,0.612526391020149,0.9547454301352887,0.46798112306436246,"['NOTCH3', 'NOTCH1', 'TGFB1', 'ANGPT1', 'NOTCH4', 'EPHB2', 'RELB', 'MAPK3']",0.9999954048088422,0,0,8
320,The influence of laminopathies on Wnt signaling WP4844,0.612526391020149,0.9547454301352887,0.46798112306436246,"['CEBPA', 'CEBPB', 'ICMT', 'TCF7', 'HMGA2', 'HES1', 'PPARG', 'HES5']",0.9999954048088422,0,0,8
321,IL-3 signaling pathway WP286,0.6232471711015989,0.9434944734965534,0.44609559913984487,"['HCK', 'JUN', 'TGFB1', 'YWHAB', 'BAD', 'BCL2', 'PTPN6', 'FOS', 'JAK2', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,11
322,Regulation of Microtubule Cytoskeleton WP2038,0.6232471711015989,0.9434944734965534,0.44609559913984487,"['SPRED1', 'PARD6A', 'ROCK1', 'CFL2', 'STMN1', 'RHO', 'ABL1', 'CDK1', 'RAC1', 'EPHB2', 'PHLDB2']",0.9999954048088422,0,0,11
323,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6427152677564283,0.9330778386098548,0.4124702974916057,"['ITGB4', 'TCF7', 'CACNA2D3', 'CACNA1C', 'ACTB', 'ACTG1', 'CACNG6', 'ITGA10', 'ITGA11', 'ITGA8', 'ITGB8', 'DMD', 'ITGA5', 'CTNNA2', 'CACNG2', 'CACNG4', 'CACNG5']",0.9999954048088422,0,0,17
324,Physiological and pathological hypertrophy of the heart WP1528,0.6507374282028083,0.9149256093700538,0.39309692275614205,"['EDN1', 'JUN', 'RAC1', 'FOS', 'CALM1', 'CALM2']",0.9999954048088422,0,0,6
325,PDGFR-beta pathway WP3972,0.650973472231905,0.9149054064751049,0.39275643626766005,"['JUN', 'STAT1', 'FOS', 'JAK2', 'ELK1', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,7
326,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6515583698408676,0.9149458026742622,0.39195207098706036,"['B3GALNT1', 'SPHK1', 'B3GALT1', 'SGMS2', 'ST6GALNAC3']",0.9999954048088422,0,0,5
327,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.6515583698408676,0.9149458026742622,0.39195207098706036,"['EGLN2', 'CFLAR', 'SELE', 'BCL2L2', 'RELB']",0.9999954048088422,0,0,5
328,Purine metabolism and related disorders WP4224,0.6515583698408676,0.9149458026742622,0.39195207098706036,"['PRPS1', 'GRM5', 'RRM2B', 'AOX1', 'APRT']",0.9999954048088422,0,0,5
329,Melatonin metabolism and effects WP3298,0.65186838109662,0.9148851939825812,0.39149090838738443,"['PER2', 'EDN1', 'IRAK1', 'CYP1B1', 'CYP2C19', 'CALM1', 'CALM2', 'FOXO1']",0.9999954048088422,0,0,8
330,Neural Crest Cell Migration during Development WP4564,0.65186838109662,0.9148851939825812,0.39149090838738443,"['ARF1', 'JUN', 'BDNF', 'CDH11', 'RAC1', 'FOS', 'EPHB2', 'EPHB3']",0.9999954048088422,0,0,8
331,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6531921938042687,0.9148649718856419,0.38962623352353853,"['GABRA1', 'GABRB1', 'SLC12A5', 'ROCK1', 'BDNF', 'JAK2', 'GABRE', 'GABRD', 'GABRG3']",0.9999954048088422,0,0,9
332,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6545297544655718,0.9528369333738972,0.40384872246150433,"['CDKN1A', 'CDKN1B', 'CHRM1', 'CSF3R', 'FLT1', 'ITGB4', 'SLC2A3', 'HIF3A', 'FGF1', 'IGF1R', 'RPTOR', 'GYS2', 'GHR', 'LIPE', 'GYS1', 'CREB3L1', 'TNR', 'ITGB8', 'IKBKG', 'NOS1', 'JAK2', 'PELO', 'HRAS', 'HSP90AA1', 'IL4R', 'HGF', 'RPS6', 'F2R', 'PRLR', 'CREB3', 'CDC37', 'ITGA8', 'ITGA5', 'ATF4', 'EPAS1', 'EFNA5', 'THBS1', 'EGFR', 'FOXO1', 'THBS4', 'GNG10', 'GNG3', 'PDGFC', 'EIF4B', 'MAPK3', 'ANGPT2', 'ANGPT1', 'LAMB3', 'LAMB2', 'BAD', 'FN1', 'VEGFB', 'GNG11', 'COL1A1', 'FGF17', 'EFNA3', 'FGF14', 'RAB14', 'LPAR6', 'COL5A3', 'ITGA10', 'ITGA11', 'KRAS', 'FGFR4', 'FGFR3', 'FGF10']",0.9999954048088422,0,0,66
333,Common Pathways Underlying Drug Addiction WP2636,0.654803420893653,0.9148447401774398,0.387363751239602,"['GRIA1', 'PPP1CC', 'GRM5', 'DRD2', 'CALM1', 'CALM2', 'GRM1', 'ACTB', 'ACTG1', 'MAPK3']",0.9999954048088422,0,0,10
334,Copper homeostasis WP3286,0.654803420893653,0.9148447401774398,0.387363751239602,"['PRNP', 'JUN', 'STEAP4', 'SCO2', 'COX17', 'XAF1', 'SOD3', 'FOXO1', 'ATOX1', 'SOD1']",0.9999954048088422,0,0,10
335,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.6566107332917677,0.9148244988511212,0.3848336664534686,"['ABCA1', 'CYP27A1', 'IDI1', 'SQLE', 'HMGCS1', 'ELOVL2', 'PMVK', 'MSMO1', 'DHCR24', 'DHCR7', 'TM7SF2']",0.9999954048088422,0,0,11
336,Cancer immunotherapy by CTLA4 blockade WP4582,0.6602351284264667,0.9149861605377619,0.37986497019489057,"['CD80', 'PTPN6', 'HLA-DRB1']",0.9999954048088422,0,0,3
337,Genes targeted by miRNAs in adipocytes WP1992,0.6602351284264667,0.9149861605377619,0.37986497019489057,"['KCNE1', 'TMSB4X', 'KCNQ1']",0.9999954048088422,0,0,3
338,Iron metabolism in placenta WP2007,0.6602351284264667,0.9149861605377619,0.37986497019489057,"['TF', 'HEPHL1', 'FTH1']",0.9999954048088422,0,0,3
339,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.6602351284264667,0.9149861605377619,0.37986497019489057,"['ZEB1', 'JAK2', 'SOX4']",0.9999954048088422,0,0,3
340,Genotoxicity pathway WP4286,0.6605877752654866,0.9147839873166865,0.3792925592866307,"['IKBIP', 'PLK3', 'BTG2', 'CDKN1A', 'GADD45A', 'PCDH8', 'TRIAP1', 'ACTA2', 'RPS27', 'RRM2B', 'SERTAD1', 'BLOC1S2', 'PHLDA3']",0.9999954048088422,0,0,13
341,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6669885754434624,0.9147231477074409,0.3704467404625228,"['KIRREL3', 'CDKN1A', 'CDKN1B', 'TRPC6', 'KIRREL2', 'NOTCH1', 'TGFB1', 'MME', 'ITGB4', 'LAMB2', 'CD80', 'PTPRO', 'DKK1', 'PAX2', 'COL4A3', 'UTRN']",0.9999954048088422,0,0,16
342,16p11.2 proximal deletion syndrome WP4949,0.6691666814339056,0.9147028485281282,0.3674563489682955,"['MSN', 'GDPD3', 'TBX6', 'SEZ6L2', 'CORO1A', 'CCT6A', 'CASP8', 'ASPHD1', 'PPP4R4', 'TCP1', 'TMEM219', 'PPARG', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3', 'MAPK3']",0.9999954048088422,0,0,17
343,Estrogen metabolism WP697,0.6739115746358141,0.9150063251106895,0.3611130762400076,"['CYP1B1', 'CYP3A4']",0.9999954048088422,0,0,2
344,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.6739115746358141,0.9150063251106895,0.3611130762400076,"['ELOB', 'ELOC']",0.9999954048088422,0,0,2
345,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.6739115746358141,0.9150063251106895,0.3611130762400076,"['IRAK1', 'TIFA']",0.9999954048088422,0,0,2
346,Macrophage markers WP4146,0.6739115746358141,0.9150063251106895,0.3611130762400076,"['CD83', 'CD68']",0.9999954048088422,0,0,2
347,NAD Biosynthesis II (from tryptophan) WP2485,0.6739115746358141,0.9150063251106895,0.3611130762400076,"['HAAO', 'KMO']",0.9999954048088422,0,0,2
348,Vitamin D Metabolism WP1531,0.6739115746358141,0.9150063251106895,0.3611130762400076,"['CYP27A1', 'DHCR7']",0.9999954048088422,0,0,2
349,G13 Signaling Pathway WP524,0.688089062449956,0.8821148559209856,0.3297671697976114,"['ROCK1', 'CFL2', 'ARHGDIB', 'CFL1', 'ARHGDIG', 'RAC1', 'IQGAP2', 'CALM1', 'CALM2']",0.9999954048088422,0,0,9
350,Lung fibrosis WP3624,0.688089062449956,0.8821148559209856,0.3297671697976114,"['EDN1', 'CEBPB', 'TGFB1', 'IL5', 'HGF', 'FAM13A', 'HMOX1', 'PTX3', 'FGF1']",0.9999954048088422,0,0,9
351,Oxidative Damage WP3941,0.688089062449956,0.8821148559209856,0.3297671697976114,"['CDKN1A', 'CDKN1B', 'BAD', 'GADD45A', 'C5AR1', 'BCL2', 'CYCS', 'TNFRSF1B', 'NFKBIE']",0.9999954048088422,0,0,9
352,Nuclear receptors WP170,0.6887782250204898,0.8782137767220902,0.3274296583403921,"['NR4A2', 'NR4A1', 'NR1I3', 'HNF4A', 'RORA', 'ROR1', 'PPARG', 'NR2F6']",0.9999954048088422,0,0,8
353,Target Of Rapamycin (TOR) Signaling WP1471,0.6887782250204898,0.8782137767220902,0.3274296583403921,"['RPTOR', 'FKBP1A', 'IDI1', 'RRAGA', 'RRAGC', 'PRKAG2', 'PRR5L', 'RAC1']",0.9999954048088422,0,0,8
354,AMP-activated protein kinase (AMPK) signaling WP1403,0.6918820072206705,0.8947801259969587,0.3295831753343795,"['CDKN1A', 'STRADB', 'PRKAG2', 'ADRA1B', 'EEF2', 'ADRA1A', 'CPT1B', 'ACACB', 'GYS2', 'RPTOR', 'GYS1', 'LIPE', 'HNF4A', 'LEP', 'LEPR']",0.9999954048088422,0,0,15
355,Ovarian infertility WP34,0.6928820927659928,0.8666966561703404,0.3179870463116605,"['EGR1', 'CEBPB', 'CDKN1B', 'PTGER2', 'SMPD1', 'PRLR']",0.9999954048088422,0,0,6
356,Eicosanoid Synthesis WP167,0.6972396938352419,0.8576875148350345,0.30930444666768525,"['PTGES2', 'ALOX15', 'ALOX12', 'PTGDS', 'PTGS1']",0.9999954048088422,0,0,5
357,Immune response to tuberculosis WP4197,0.6972396938352419,0.8576875148350345,0.30930444666768525,"['STAT1', 'TAP1', 'IFIT1', 'JAK2', 'IFIT3']",0.9999954048088422,0,0,5
358,Hepatitis B infection WP4666,0.7005116965332213,0.9143971970058926,0.3254743933441866,"['CDKN1A', 'YWHAB', 'ELK1', 'CASP8', 'IRAK1', 'MYC', 'CREB3L1', 'FADD', 'IKBKG', 'JAK2', 'HRAS', 'MAPK3', 'JUN', 'EGR2', 'TICAM2', 'TGFB1', 'EGR3', 'ATP6AP1', 'SLC10A1', 'STAT1', 'BAD', 'NFATC3', 'NFATC2', 'FOS', 'TGFBR2', 'CREB3', 'VDAC3', 'BCL2', 'CYCS', 'BAX', 'KRAS', 'ATF4']",0.9999954048088422,0,0,32
359,Complement Activation WP545,0.7043948996198267,0.8445109707568179,0.2959302772039495,"['C3', 'C6', 'C9', 'MASP2']",0.9999954048088422,0,0,4
360,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.7043948996198267,0.8445109707568179,0.2959302772039495,"['TJP1', 'JUN', 'PXN', 'MAPK3']",0.9999954048088422,0,0,4
361,PPAR-alpha pathway WP2878,0.7043948996198267,0.8445109707568179,0.2959302772039495,"['CPT2', 'MYC', 'CDK1', 'APOA1']",0.9999954048088422,0,0,4
362,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.7043948996198267,0.8445109707568179,0.2959302772039495,"['TGFB1', 'CDH1', 'FN1', 'MAPK3']",0.9999954048088422,0,0,4
363,22q11.2 copy number variation syndrome WP4657,0.7053324473138448,0.9019538675603113,0.3148594956311531,"['TBX1', 'RANBP1', 'OAT', 'SERPIND1', 'EMC10', 'GP1BA', 'RTN4', 'EGFR', 'SLC7A4', 'ACTA2', 'CLDN5', 'CYP26B1', 'MRPL40', 'ACTC1', 'THAP7', 'CLTCL1', 'BCL2', 'RCC1', 'DGCR6L', 'HES1', 'DRD2', 'HIST1H4C', 'RAN', 'FGF10']",0.9999954048088422,0,0,24
364,Aflatoxin B1 metabolism WP699,0.7113798411299403,0.9150264801201486,0.3116111302151145,['CYP3A4'],0.9999954048088422,0,0,1
365,COVID-19 adverse outcome pathway WP4891,0.7113798411299403,0.9150264801201486,0.3116111302151145,['IL7'],0.9999954048088422,0,0,1
366,Hypothetical Craniofacial Development Pathway WP3655,0.7113798411299403,0.9150264801201486,0.3116111302151145,['TP63'],0.9999954048088422,0,0,1
367,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.7113798411299403,0.9150264801201486,0.3116111302151145,['NRP1'],0.9999954048088422,0,0,1
368,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.7113798411299403,0.9150264801201486,0.3116111302151145,['CHRM1'],0.9999954048088422,0,0,1
369,Vitamin B6-dependent and responsive disorders WP4228,0.7113798411299403,0.9150264801201486,0.3116111302151145,['PNPO'],0.9999954048088422,0,0,1
370,Cysteine and methionine catabolism WP4504,0.7165017870456281,0.8234163701067616,0.27450605162422054,"['AHCY', 'GOT1', 'SQOR']",0.9999954048088422,0,0,3
371,FOXA2 pathway WP5066,0.7165017870456281,0.8234163701067616,0.27450605162422054,"['ABCC3', 'ABCC2', 'FOXO1']",0.9999954048088422,0,0,3
372,Ganglio Sphingolipid Metabolism WP1423,0.7165017870456281,0.8234163701067616,0.27450605162422054,"['B3GALT1', 'B3GALT4', 'FUT1']",0.9999954048088422,0,0,3
373,Glutathione metabolism WP100,0.7165017870456281,0.8234163701067616,0.27450605162422054,"['GPX2', 'GPX4', 'GPX3']",0.9999954048088422,0,0,3
374,Major receptors targeted by epinephrine and norepinephrine WP4589,0.7165017870456281,0.8234163701067616,0.27450605162422054,"['ADCY10', 'ADCY9', 'ADRA1D']",0.9999954048088422,0,0,3
375,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7172765869156286,0.8700095704880949,0.28909874876634595,"['YAP1', 'DCLRE1C', 'H2AFX', 'ACTL6A', 'RAD51', 'KAT5', 'CDK5', 'E2F1', 'ABL1', 'NABP2', 'BAX', 'MCPH1', 'RAD9A']",0.9999954048088422,0,0,13
376,Breast cancer pathway WP4262,0.7200218364228603,0.9051541218637993,0.2973193588403714,"['SHC4', 'NOTCH3', 'CDKN1A', 'NOTCH1', 'NOTCH4', 'TCF7', 'FGF1', 'EGFR', 'IGF1R', 'DLL3', 'WNT6', 'FRAT1', 'FRAT2', 'HEY1', 'MYC', 'E2F1', 'HES1', 'HRAS', 'HES5', 'SKP1', 'MAPK3', 'WNT10A', 'JUN', 'WNT5B', 'GADD45B', 'GADD45A', 'FOS', 'FGF17', 'SFRP4', 'RAD51', 'BAX', 'KRAS', 'FGF10']",0.9999954048088422,0,0,33
377,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7231141431869226,0.8443632377124064,0.27373259386557863,"['JUN', 'HGF', 'PXN', 'GAB1', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,8
378,Genes controlling nephrogenesis WP4823,0.7265625161556453,0.8352038656520706,0.2667897959809205,"['ROBO2', 'EYA1', 'LAMB2', 'ITGA8', 'ETV4', 'GLI3', 'PAX2']",0.9999954048088422,0,0,7
379,Tumor suppressor activity of SMARCB1 WP4204,0.7265625161556453,0.8352038656520706,0.2667897959809205,"['H3F3B', 'SMO', 'PTCH1', 'ACTL6A', 'DPF3', 'GLI3', 'GLI2']",0.9999954048088422,0,0,7
380,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7314942083278314,0.8232905982905983,0.25741495851358026,"['CDKN1A', 'RBL1', 'STAT1', 'PTH1R', 'FGFR3', 'MAPK3']",0.9999954048088422,0,0,6
381,Gastric Cancer Network 2 WP2363,0.7314942083278314,0.8232905982905983,0.25741495851358026,"['FANCI', 'MYC', 'S100A6', 'CACYBP', 'COL9A3', 'EGFR']",0.9999954048088422,0,0,6
382,Signal transduction through IL1R WP4496,0.7314942083278314,0.8232905982905983,0.25741495851358026,"['NFKBIA', 'JUN', 'TGFB1', 'IRAK1', 'TOLLIP', 'MAP3K14']",0.9999954048088422,0,0,6
383,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7385998902074021,0.8071654961533629,0.2445702778037207,"['HPGD', 'ACOX2', 'PTGDS', 'PTGS1', 'PTGDR']",0.9999954048088422,0,0,5
384,Cell Differentiation - Index WP2029,0.7387641692884662,0.7842233667660613,0.23744443001655152,"['LEFTY1', 'MEF2D']",0.9999954048088422,0,0,2
385,Estrogen Receptor Pathway WP2881,0.7387641692884662,0.7842233667660613,0.23744443001655152,"['JUN', 'CYP1B1']",0.9999954048088422,0,0,2
386,Leptin and adiponectin WP3934,0.7387641692884662,0.7842233667660613,0.23744443001655152,"['LEP', 'LEPR']",0.9999954048088422,0,0,2
387,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.7387641692884662,0.7842233667660613,0.23744443001655152,"['AHCY', 'MAT2B']",0.9999954048088422,0,0,2
388,NLR Proteins WP288,0.7387641692884662,0.7842233667660613,0.23744443001655152,"['IKBKG', 'EPHB2']",0.9999954048088422,0,0,2
389,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.7387641692884662,0.7842233667660613,0.23744443001655152,"['ELK1', 'MEF2D']",0.9999954048088422,0,0,2
390,Thiamine metabolic pathways WP4297,0.7387641692884662,0.7842233667660613,0.23744443001655152,"['BCKDK', 'TKT']",0.9999954048088422,0,0,2
391,Vitamin B12 Disorders WP4271,0.7387641692884662,0.7842233667660613,0.23744443001655152,"['CUBN', 'TCN1']",0.9999954048088422,0,0,2
392,Small cell lung cancer WP4658,0.7435444383313075,0.8746079772315939,0.259169735709377,"['CDKN1A', 'CDKN2B', 'CDKN1B', 'LAMB3', 'GADD45B', 'LAMB2', 'GADD45A', 'LAMB4', 'FN1', 'FHIT', 'CKS1B', 'NFKBIA', 'CASP8', 'CCNE2', 'MYC', 'COL4A3', 'E2F1', 'BCL2', 'CYCS', 'BAX', 'IKBKG', 'SKP1']",0.9999954048088422,0,0,22
393,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7444114763430897,0.844215223673141,0.24917969449746702,"['BEX3', 'SOCS3', 'CDKN1A', 'CDKN1B', 'HSPA5', 'F2R', 'ABL1', 'HSPB1', 'NRG1', 'RNF7', 'THBS1', 'IER3']",0.9999954048088422,0,0,12
394,Cardiac Hypertrophic Response WP2795,0.7444114763430897,0.844215223673141,0.24917969449746702,"['TGFB1', 'NPPA', 'NFATC2', 'NRG1', 'RAC1', 'IKBKG', 'PRKD1', 'CALM1', 'MAP3K14', 'CALM2', 'PRKG1', 'MAPK3']",0.9999954048088422,0,0,12
395,Netrin-UNC5B signaling pathway WP4747,0.7481544352816245,0.8314609978108077,0.2412449646351392,"['YAP1', 'COL1A1', 'DCSTAMP', 'JUN', 'ITGB4', 'ALPL', 'RAC1', 'NTN1', 'SELE', 'MAPK3']",0.9999954048088422,0,0,10
396,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7481544352816245,0.8314609978108077,0.2412449646351392,"['CDKN1A', 'HSP90AA1', 'JUN', 'BCL2', 'BAX', 'FOS', 'CFLAR', 'ELK1', 'JUNB', 'EGFR']",0.9999954048088422,0,0,10
397,Apoptosis Modulation by HSP70 WP384,0.7490798584192307,0.7841209573530409,0.2265401357295995,"['CASP8', 'CASP6', 'CYCS', 'FADD']",0.9999954048088422,0,0,4
398,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.7490798584192307,0.7841209573530409,0.2265401357295995,"['TGFB1', 'IL4R', 'CD80', 'TGFBR2']",0.9999954048088422,0,0,4
399,PDGF Pathway WP2526,0.7510166674341998,0.8231646471846045,0.2356946210316603,"['NFKBIA', 'JUN', 'STAT1', 'ARFIP2', 'RAC1', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,9
400,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7548039529324317,0.8130201460367731,0.22870031374770292,"['RPTOR', 'MAP1LC3A', 'EIF2B2', 'MSTN', 'IGFBP5', 'TNFSF9', 'NEB', 'IGF1R']",0.9999954048088422,0,0,8
401,Neural Crest Cell Migration in Cancer WP4565,0.7548039529324317,0.8130201460367731,0.22870031374770292,"['ARF1', 'JUN', 'BDNF', 'CDH11', 'RAC1', 'FOS', 'EPHB2', 'EPHB3']",0.9999954048088422,0,0,8
402,Corticotropin-releasing hormone signaling pathway WP2355,0.7627521618847823,0.8543876567020251,0.23138707739546757,"['GNAZ', 'HSP90AA1', 'TGFB1', 'HSD3B1', 'IL18', 'FOS', 'ELK1', 'TBX19', 'NR4A2', 'NFKBIA', 'POMC', 'NR4A1', 'STAR', 'CYP21A2', 'CRH', 'BCL2', 'JUNB', 'RAPGEF3', 'MAPK3']",0.9999954048088422,0,0,19
403,Thermogenesis WP4321,0.7634207155872762,0.8661245388148483,0.23380685742707244,"['KLB', 'RPS6', 'ACTL6A', 'UCP1', 'ACSL5', 'PRKAG2', 'CPT1B', 'ACTB', 'ACTG1', 'RPTOR', 'LIPE', 'ADCY10', 'CREB3', 'ADCY9', 'CPT2', 'RPS6KA2', 'CREB3L1', 'ZNF516', 'DPF3', 'PPARG', 'KRAS', 'PLIN1', 'HRAS', 'PRKG1']",0.9999954048088422,0,0,24
404,Cell Differentiation - Index expanded WP2023,0.7652412136508252,0.7484956324813976,0.2002706223046935,"['LEFTY1', 'PAX7', 'MEF2D']",0.9999954048088422,0,0,3
405,Riboflavin and CoQ disorders WP5037,0.7652412136508252,0.7484956324813976,0.2002706223046935,"['SLC52A2', 'RFK', 'PDSS2']",0.9999954048088422,0,0,3
406,Type II diabetes mellitus WP1584,0.7652412136508252,0.7484956324813976,0.2002706223046935,"['SURF1', 'KCNJ11', 'CACNA1A']",0.9999954048088422,0,0,3
407,Lipid Metabolism Pathway WP3965,0.7665321497545433,0.7840184506851173,0.20845375781092693,"['LIPE', 'ACLY', 'PRKAR1A', 'HILPDA', 'PRKAG2', 'PLIN1']",0.9999954048088422,0,0,6
408,Nanoparticle-mediated activation of receptor signaling WP2643,0.7665321497545433,0.7840184506851173,0.20845375781092693,"['COL1A1', 'PXN', 'FN1', 'KRAS', 'HRAS', 'EGFR']",0.9999954048088422,0,0,6
409,Sphingolipid Metabolism (general overview) WP4725,0.7756505761814705,0.7622570351029881,0.19365379983719708,"['CERS4', 'SPHK1', 'SMPD1', 'DEGS1', 'SGMS2']",0.9999954048088422,0,0,5
410,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7838358491826485,0.7839158466236851,0.19092713874082737,"['PRKCH', 'PLCB4', 'STAR', 'HSD3B1', 'KRAS', 'AMH', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,8
411,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7840142030572078,0.8700372208436724,0.2117045409855001,"['NOTCH3', 'SPARC', 'NOTCH1', 'NOTCH4', 'EIF5A2', 'TWIST2', 'WNT8A', 'CLDN2', 'FOXM1', 'DLL3', 'WNT6', 'CLDN20', 'CDH1', 'HRAS', 'MEF2D', 'MAPK3', 'WNT10A', 'TGFB1', 'WNT5B', 'FN1', 'WNT9A', 'TGFBR2', 'TJP1', 'CLDN5', 'CLDN4', 'ZEB1', 'CLDN9', 'CLDN14', 'COL4A3', 'STRAP', 'CLDN18', 'KRAS', 'ITGA5']",0.9999954048088422,0,0,33
412,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7850584655610265,0.828069293148815,0.2003903555766366,"['WNT10A', 'JUN', 'WNT5B', 'SERPINF1', 'TCF7', 'DKK1', 'CXXC4', 'DKK2', 'SFRP4', 'WNT6', 'FRAT1', 'CCND3', 'FRAT2', 'SFRP2', 'MYC', 'ROR1']",0.9999954048088422,0,0,16
413,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7883813145289775,0.7317829457364341,0.17399852234844979,"['LDHA', 'CD80', 'MYC', 'SLC2A3']",0.9999954048088422,0,0,4
414,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7883813145289775,0.7317829457364341,0.17399852234844979,"['GSDMD', 'NFKBIA', 'IKBKG', 'NFKBIE']",0.9999954048088422,0,0,4
415,Benzene metabolism WP3891,0.7884643049384689,0.6862105762390325,0.16309039348577598,['MPO'],0.9999954048088422,0,0,1
416,EV release from cardiac cells and their functional effects WP3297,0.7884643049384689,0.6862105762390325,0.16309039348577598,['ERBB4'],0.9999954048088422,0,0,1
417,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.7884643049384689,0.6862105762390325,0.16309039348577598,['ELOVL2'],0.9999954048088422,0,0,1
418,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.7884643049384689,0.6862105762390325,0.16309039348577598,['RAC1'],0.9999954048088422,0,0,1
419,The alternative pathway of fetal androgen synthesis WP4524,0.7884643049384689,0.6862105762390325,0.16309039348577598,['STAR'],0.9999954048088422,0,0,1
420,Alpha 6 Beta 4 signaling pathway WP244,0.7900502748116603,0.768254571360722,0.18104587090071697,"['LAMB3', 'ITGB4', 'LAMB2', 'GAB1', 'RAC1', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,7
421,BDNF-TrkB Signaling WP3676,0.7900502748116603,0.768254571360722,0.18104587090071697,"['ARC', 'TRPC6', 'HOMER1', 'BDNF', 'GAB1', 'KRAS', 'HRAS']",0.9999954048088422,0,0,7
422,Fatty acid beta-oxidation WP143,0.7900502748116603,0.768254571360722,0.18104587090071697,"['LIPE', 'TPI1', 'CPT2', 'ACADL', 'LPL', 'ACSL5', 'CPT1B']",0.9999954048088422,0,0,7
423,Dopamine metabolism WP2436,0.7922404287894577,0.6861361480075902,0.15979449556994768,"['TYR', 'SOD1']",0.9999954048088422,0,0,2
424,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.7922404287894577,0.6861361480075902,0.15979449556994768,"['MAFF', 'MAFK']",0.9999954048088422,0,0,2
425,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.7922404287894577,0.6861361480075902,0.15979449556994768,"['MYC', 'FN1']",0.9999954048088422,0,0,2
426,Valproic acid pathway WP3871,0.7922404287894577,0.6861361480075902,0.15979449556994768,"['CYP2A6', 'ACSM1']",0.9999954048088422,0,0,2
427,Neural Crest Differentiation WP2064,0.8007195354910613,0.8271205918264741,0.18382303230004413,"['NOTCH3', 'NOTCH1', 'HDAC10', 'MIA', 'NOTCH4', 'WNT8A', 'MITF', 'TBX6', 'GFAP', 'RHOB', 'DLL3', 'CDH1', 'PAX7', 'MYC', 'ZIC1', 'HES1', 'FGFR3', 'HES5', 'SOX5']",0.9999954048088422,0,0,19
428,Sphingolipid Metabolism (integrated pathway) WP4726,0.8085224091354929,0.7220757804789686,0.15347495673536057,"['CERS4', 'SMPD1', 'SPHK1', 'DEGS1', 'SGMS2']",0.9999954048088422,0,0,5
429,Hedgehog Signaling Pathway WP4249,0.8102487200520557,0.7568187402735687,0.15924527102211247,"['EVC', 'SMO', 'HHIP', 'SUFU', 'PTCH1', 'BCL2', 'GLI3', 'GLI2']",0.9999954048088422,0,0,8
430,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8102487200520557,0.7568187402735687,0.15924527102211247,"['NFKBIA', 'JUN', 'CASP8', 'FADD', 'RAC1', 'MAP3K14', 'RELB', 'MAPK3']",0.9999954048088422,0,0,8
431,Osteoblast differentiation WP4787,0.8135150062068808,0.833016424910813,0.1719270146659113,"['HES6', 'NOTCH3', 'WNT10A', 'PRKCH', 'NOTCH1', 'WNT5B', 'STAT1', 'NOTCH4', 'PTCH1', 'WNT8A', 'WNT9A', 'FGF1', 'GLI3', 'GLI2', 'DLL3', 'WNT6', 'SMO', 'HEY1', 'PPARG', 'PRKD1', 'FGFR4', 'FGFR3', 'FGF10', 'MAPK3']",0.9999954048088422,0,0,24
432,MAPK Cascade WP422,0.8173157874844684,0.7386423835010869,0.14900613450914074,"['JUN', 'RRAS', 'KRAS', 'ELK1', 'HRAS', 'SIPA1', 'MAPK3']",0.9999954048088422,0,0,7
433,Sphingolipid pathway WP1422,0.8261672197685291,0.7157190635451505,0.1366723387021987,"['CERS4', 'ACER1', 'GAL3ST1', 'SPHK1', 'SERINC1', 'SGMS2']",0.9999954048088422,0,0,6
434,Eukaryotic Transcription Initiation WP405,0.8278385625059411,0.7481371087928465,0.1413508680262011,"['TAF13', 'POLR2E', 'POLR1E', 'TAF7', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.9999954048088422,0,0,9
435,Osteopontin Signaling WP1434,0.8357905722242287,0.6098460889732237,0.10939248934387133,"['MAP3K14', 'MAPK3']",0.9999954048088422,0,0,2
436,Purine metabolism WP4792,0.8357905722242287,0.6098460889732237,0.10939248934387133,"['PRPS1', 'APRT']",0.9999954048088422,0,0,2
437,Cannabinoid receptor signaling WP3869,0.8374324392072937,0.685912651317351,0.12169097912482685,"['ADORA2A', 'PRKAR1A', 'CYP2C19', 'CYP3A4', 'MAPK3']",0.9999954048088422,0,0,5
438,NAD+ metabolism WP3644,0.8421635279424865,0.6332329592116069,0.10877743522198946,"['NRK', 'CD38', 'NMNAT3']",0.9999954048088422,0,0,3
439,Overview of interferons-mediated signaling pathway WP4558,0.8421635279424865,0.6332329592116069,0.10877743522198946,"['STAT1', 'IFNE', 'JAK2']",0.9999954048088422,0,0,3
440,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8433143150703593,0.7413164114685027,0.1263318347053251,"['NFKBIA', 'RPS6KA5', 'IRAK1', 'MYC', 'TOLLIP', 'MKNK2', 'FOS', 'ELK1', 'MAP3K14', 'MAPK3']",0.9999954048088422,0,0,10
441,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8433143150703593,0.7413164114685027,0.1263318347053251,"['RPTOR', 'ARC', 'HOMER1', 'BDNF', 'PRKAG2', 'KRAS', 'CACNA1C', 'HRAS', 'GRM1', 'MAPK3']",0.9999954048088422,0,0,10
442,FOXP3 in COVID-19 WP5063,0.8449645662007035,0.5489210339103628,0.09247155903724012,['CD80'],0.9999954048088422,0,0,1
443,Insulin signaling in adipocytes (diabetic condition) WP3635,0.8449645662007035,0.5489210339103628,0.09247155903724012,['RPS6'],0.9999954048088422,0,0,1
444,Insulin signaling in adipocytes (normal condition) WP3634,0.8449645662007035,0.5489210339103628,0.09247155903724012,['RPS6'],0.9999954048088422,0,0,1
445,Metastatic brain tumor WP2249,0.8449645662007035,0.5489210339103628,0.09247155903724012,['MYC'],0.9999954048088422,0,0,1
446,miRNA Biogenesis WP2338,0.8449645662007035,0.5489210339103628,0.09247155903724012,['RAN'],0.9999954048088422,0,0,1
447,Molybdenum cofactor (Moco) biosynthesis WP4507,0.8449645662007035,0.5489210339103628,0.09247155903724012,['AOX1'],0.9999954048088422,0,0,1
448,"Phase I biotransformations, non P450 WP136",0.8449645662007035,0.5489210339103628,0.09247155903724012,['PON1'],0.9999954048088422,0,0,1
449,SARS-CoV-2 and COVID-19 Pathway WP4846,0.8449645662007035,0.5489210339103628,0.09247155903724012,['NRP1'],0.9999954048088422,0,0,1
450,p53 transcriptional gene network WP4963,0.8488586746780358,0.7585498519998988,0.12429792628599476,"['BTG2', 'CDKN1A', 'NOTCH1', 'SIVA1', 'NCF2', 'GADD45A', 'ISG15', 'SLC7A11', 'THBS1', 'DRAM1', 'RRM2B', 'SESN1', 'BAX']",0.9999954048088422,0,0,13
451,Interleukin-11 Signaling Pathway WP2332,0.8489313856934801,0.7260701857364471,0.11891353417130726,"['SOCS3', 'TGFB1', 'STAT1', 'FES', 'RPS6', 'BCL2', 'JAK2', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,9
452,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8512218922224137,0.7834013605442177,0.12619220381461665,"['SHC4', 'BAD', 'HGF', 'RPS6', 'GAB1', 'NRG1', 'EGFR', 'IGF1R', 'RRAS', 'MYC', 'PDGFC', 'BCL2', 'BAX', 'KRAS', 'JAK2', 'HRAS', 'FGFR3', 'MAPK3']",0.9999954048088422,0,0,18
453,Angiogenesis WP1539,0.8520804214811618,0.645579161897317,0.10334067452550895,"['FLT1', 'ANGPT1', 'TIMP2', 'TIMP3']",0.9999954048088422,0,0,4
454,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8520804214811618,0.645579161897317,0.10334067452550895,"['H3F3B', 'SUV39H1', 'E2F1', 'HIST1H3E']",0.9999954048088422,0,0,4
455,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8520804214811618,0.645579161897317,0.10334067452550895,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.9999954048088422,0,0,4
456,Kit receptor signaling pathway WP304,0.8526643082483861,0.7479574633640255,0.11921645499597737,"['STAT1', 'BAD', 'RPS6', 'BCL2', 'MITF', 'PTPN6', 'FOS', 'JAK2', 'JUNB', 'HRAS', 'SH2B2', 'MAPK3']",0.9999954048088422,0,0,12
457,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8608794407824697,0.8196078606480882,0.1227779186850892,"['SHC4', 'GRIA1', 'RAB3A', 'NCF2', 'ELK1', 'ACACB', 'GRIP1', 'RPS6KA5', 'CFL1', 'RACK1', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'SH2B2', 'MAPK3', 'NSF', 'NTRK1', 'EGR1', 'JUN', 'EGR2', 'BDNF', 'STAT1', 'BAD', 'RPS6', 'FOS', 'EEF2', 'NFKBIA', 'MARCKS', 'CDK5', 'ALPL', 'CDK5R1']",0.9999954048088422,0,0,32
458,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8617498768072496,0.7527471502397344,0.11200141148528522,"['PTPRT', 'DUSP2', 'CSF3R', 'F2R', 'MPL', 'MAPK15', 'EGFR', 'GHR', 'RPTOR', 'SOCS3', 'STMN1', 'JAK2', 'MAPK3', 'IL12RB2']",0.9999954048088422,0,0,14
459,Ebola Virus Pathway on Host WP4217,0.8666758821691702,0.7968014243007449,0.11401448347020234,"['VPS4A', 'ACTB', 'EGFR', 'IGF1R', 'ACTG1', 'RELB', 'SOCS3', 'C1QBP', 'CLTCL1', 'FLNB', 'RAC1', 'CTSB', 'MAPK3', 'VPS18', 'CAV3', 'CAV2', 'STAT1', 'HLA-B', 'HLA-C', 'HLA-E', 'RHOB', 'BST2', 'NEDD4', 'ITGA5', 'HLA-DRB1']",0.9999954048088422,0,0,25
460,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8677779085063257,0.7640881757270908,0.10836257464182752,"['WNT10A', 'JUN', 'WNT5B', 'SERPINF1', 'TCF7', 'DKK1', 'CXXC4', 'DKK2', 'SFRP4', 'WNT6', 'FRAT1', 'CCND3', 'FRAT2', 'SFRP2', 'HNRNPK', 'MYC', 'ROR1']",0.9999954048088422,0,0,17
461,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.8709015786153347,0.5488140417457306,0.07586053803356656,"['DKK1', 'FOXO1']",0.9999954048088422,0,0,2
462,15q13.3 copy number variation syndrome WP4942,0.8716853104228074,0.5879511947127606,0.08074145774270224,"['GOLGA8H', 'OTUD7A', 'CHRFAM7A']",0.9999954048088422,0,0,3
463,Canonical and non-canonical TGF-B signaling WP3874,0.8716853104228074,0.5879511947127606,0.08074145774270224,"['TGFB1', 'LOXL1', 'TGFBR2']",0.9999954048088422,0,0,3
464,1q21.1 copy number variation syndrome WP4905,0.8772982608280832,0.6096609186310183,0.07980964533158702,"['TJP1', 'PRKAG2', 'FMO5', 'TJP2']",0.9999954048088422,0,0,4
465,NAD+ biosynthetic pathways WP3645,0.8772982608280832,0.6096609186310183,0.07980964533158702,"['BST1', 'CD38', 'ACMSD', 'IDO1']",0.9999954048088422,0,0,4
466,MAPK Signaling Pathway WP382,0.8836221635781649,0.8402131909876867,0.10395598577248445,"['PTPRR', 'HSPB1', 'FGF1', 'ELK1', 'RPS6KA5', 'MYC', 'STMN1', 'RAC3', 'RAC1', 'IKBKG', 'HRAS', 'DUSP4', 'DUSP2', 'DUSP3', 'DUSP1', 'PLA2G4E', 'CACNA2D3', 'FOS', 'DUSP6', 'DUSP7', 'TGFBR2', 'DDIT3', 'ATF4', 'CACNA1B', 'CACNA1A', 'CACNA1C', 'EGFR', 'RELB', 'RASGRP3', 'CACNG6', 'PPP3R2', 'RRAS', 'MKNK2', 'FLNB', 'CACNG2', 'CACNG4', 'CACNG5', 'MAPK3', 'NTRK1', 'HSPA8', 'JUN', 'TGFB1', 'GADD45A', 'BDNF', 'NFATC3', 'FGF17', 'NR4A1', 'FGF14', 'KRAS', 'PTPN7', 'FGFR4', 'FGFR3', 'MAP3K14', 'FGF10']",0.9999954048088422,0,0,54
467,"Cerebral organic acidurias, including diseases WP4519",0.886376350617307,0.45739467235791637,0.05516803799874091,['MDH2'],0.9999954048088422,0,0,1
468,Glial Cell Differentiation WP2276,0.886376350617307,0.45739467235791637,0.05516803799874091,['MSN'],0.9999954048088422,0,0,1
469,Glucuronidation WP698,0.886376350617307,0.45739467235791637,0.05516803799874091,['PGM5'],0.9999954048088422,0,0,1
470,Ketogenesis and Ketolysis WP4742,0.886376350617307,0.45739467235791637,0.05516803799874091,['CPT2'],0.9999954048088422,0,0,1
471,Pentose Phosphate Metabolism WP134,0.886376350617307,0.45739467235791637,0.05516803799874091,['TKT'],0.9999954048088422,0,0,1
472,Type III interferon signaling WP2113,0.886376350617307,0.45739467235791637,0.05516803799874091,['STAT1'],0.9999954048088422,0,0,1
473,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.891738607563158,0.6648528035701432,0.07618031698477415,"['ACTA2', 'ACTA1', 'ACTC1', 'ITGB4', 'CDH1', 'ITGB8', 'ACTB', 'ACTG1']",0.9999954048088422,0,0,8
474,Interferon type I signaling pathways WP585,0.8941996022262086,0.6855394486692015,0.07666131264082646,"['RPTOR', 'ZAP70', 'SOCS3', 'RPS6KA5', 'STAT1', 'RPS6', 'RACK1', 'PTPN6', 'RAC1', 'EIF4B']",0.9999954048088422,0,0,10
475,RANKL/RANK signaling pathway WP2018,0.8941996022262086,0.6855394486692015,0.07666131264082646,"['NFKBIA', 'JUN', 'STAT1', 'MITF', 'TNFRSF11B', 'RAC1', 'IKBKG', 'FOS', 'RELB', 'MAPK3']",0.9999954048088422,0,0,10
476,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8962063346170474,0.5487069988137604,0.06012984156266124,"['MDH2', 'IDH3B', 'IDH3A']",0.9999954048088422,0,0,3
477,EPO Receptor Signaling WP581,0.8986977169666889,0.5775235430769615,0.06168444916265541,"['CISH', 'STAT1', 'JAK2', 'MAPK3']",0.9999954048088422,0,0,4
478,IL-9 signaling pathway WP22,0.8989741862391266,0.49887873037778163,0.05313106310197051,"['STAT1', 'MAPK3']",0.9999954048088422,0,0,2
479,Nephrogenesis WP5052,0.8989741862391266,0.49887873037778163,0.05313106310197051,"['RSPO3', 'PAX2']",0.9999954048088422,0,0,2
480,Toll-like Receptor Signaling Pathway WP75,0.8990852366935742,0.7214145284696395,0.07674222799054801,"['JUN', 'TICAM2', 'STAT1', 'CD80', 'FOS', 'NFKBIA', 'CASP8', 'IRAK1', 'TOLLIP', 'TLR9', 'FADD', 'RAC1', 'IKBKG', 'TLR5', 'MAPK3']",0.9999954048088422,0,0,15
481,Histone Modifications WP2369,0.9000901957105526,0.6670262564774325,0.07021138601457749,"['SET', 'SETBP1', 'H3F3B', 'SETD9', 'SUV39H1', 'EHMT1', 'SMYD1', 'HIST1H4C', 'HIST1H3E']",0.9999954048088422,0,0,9
482,Pancreatic adenocarcinoma pathway WP4263,0.9017674415677753,0.7363752665245202,0.07614018450146498,"['CDKN1A', 'TGFB1', 'GADD45B', 'STAT1', 'BAD', 'GADD45A', 'PEBP1', 'DUSP6', 'EGFR', 'TGFBR2', 'RAD51', 'E2F1', 'RAC3', 'BAX', 'KRAS', 'RAC1', 'IKBKG', 'MAPK3']",0.9999954048088422,0,0,18
483,Autophagy WP4923,0.9032962835162451,0.5962909833950815,0.06064557719840054,"['RPTOR', 'MAP1LC3B', 'ATG101', 'ATG9A', 'PRKAG2']",0.9999954048088422,0,0,5
484,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9032962835162451,0.5962909833950815,0.06064557719840054,"['ACTA2', 'CASP8', 'TGFB1', 'BAX', 'NOS1']",0.9999954048088422,0,0,5
485,Notch Signaling WP268,0.9067738750831973,0.6452424200083834,0.06314482389715835,"['LFNG', 'NOTCH3', 'NOTCH1', 'MAML1', 'NOTCH4', 'HES1', 'HES5', 'DLL3']",0.9999954048088422,0,0,8
486,B Cell Receptor Signaling Pathway WP23,0.9095499488917344,0.7334140590147218,0.06953158643495984,"['JUN', 'GSK3A', 'CD81', 'NFATC3', 'GAB1', 'NFATC2', 'ELK1', 'ILF2', 'FOXO1', 'RASGRP3', 'NFKBIA', 'MYC', 'SH3BP2', 'BLNK', 'PTPN6', 'RAC1', 'IKBKG', 'HRAS', 'MEF2D']",0.9999954048088422,0,0,19
487,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.9167283501277907,0.3920186998204546,0.034083708415227176,['IRAK1'],0.9999954048088422,0,0,1
488,Aspirin and miRNAs WP4707,0.9167283501277907,0.3920186998204546,0.034083708415227176,['PTGS1'],0.9999954048088422,0,0,1
489,Disorders of Folate Metabolism and Transport WP4259,0.9167283501277907,0.3920186998204546,0.034083708415227176,['ALDH1L1'],0.9999954048088422,0,0,1
490,Heme Biosynthesis WP561,0.9167283501277907,0.3920186998204546,0.034083708415227176,['UROD'],0.9999954048088422,0,0,1
491,Liver X receptor pathway WP2874,0.9167283501277907,0.3920186998204546,0.034083708415227176,['CYP3A4'],0.9999954048088422,0,0,1
492,Methylation Pathways WP704,0.9167283501277907,0.3920186998204546,0.034083708415227176,['MAT2B'],0.9999954048088422,0,0,1
493,Mitochondrial CII Assembly WP4920,0.9167283501277907,0.3920186998204546,0.034083708415227176,['SDHAF1'],0.9999954048088422,0,0,1
494,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.9167283501277907,0.3920186998204546,0.034083708415227176,['TGFB1'],0.9999954048088422,0,0,1
495,Urea cycle and related diseases WP4571,0.9167283501277907,0.3920186998204546,0.034083708415227176,['SLC25A15'],0.9999954048088422,0,0,1
496,miRNAs involvement in the immune response in sepsis WP4329,0.9167327226336154,0.5485999050783104,0.047694901893706856,"['NFKBIA', 'IRAK1', 'IKBKG', 'RELB']",0.9999954048088422,0,0,4
497,MTHFR deficiency WP4288,0.9167327226336154,0.5485999050783104,0.047694901893706856,"['CHDH', 'DNMT3A', 'EHMT1', 'CYCS']",0.9999954048088422,0,0,4
498,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.9167327226336154,0.5485999050783104,0.047694901893706856,"['CNTF', 'OMG', 'GLI2', 'SOX5']",0.9999954048088422,0,0,4
499,ATM Signaling Network in Development and Disease  WP3878,0.9199949786136374,0.6267526297930098,0.05226306352207111,"['DCLRE1C', 'KAT5', 'CDK5', 'H2AFX', 'CDK1', 'HSPB1', 'IKBKG', 'CDK5R1']",0.9999954048088422,0,0,8
500,Mammalian disorder of sexual development WP4842,0.9212629346953523,0.45726597090449084,0.037500288626850065,"['PTGDS', 'AMH']",0.9999954048088422,0,0,2
501,Focal Adhesion WP306,0.9221497530708167,0.7905751482801525,0.06407425525137189,"['SHC4', 'FLT1', 'ROCK1', 'ITGB4', 'PXN', 'ELK1', 'THBS1', 'ACTB', 'EGFR', 'THBS4', 'MYL12B', 'ACTG1', 'IGF1R', 'PPP1CC', 'CCND3', 'PDGFC', 'RAC3', 'TNR', 'ITGB8', 'FLNB', 'RAC1', 'HRAS', 'MAPK3', 'JUN', 'CAV3', 'LAMB3', 'CAV2', 'LAMB2', 'BAD', 'HGF', 'FN1', 'VEGFB', 'COL1A1', 'MYLPF', 'HCK', 'COL5A3', 'ITGA10', 'ITGA11', 'BCL2', 'ITGA8', 'ITGA5']",0.9999954048088422,0,0,41
502,Microglia Pathogen Phagocytosis Pathway WP3937,0.9230742357172239,0.5876577126577126,0.047039425360475826,"['HCK', 'NCF2', 'RAC3', 'CYBA', 'PTPN6', 'RAC1']",0.9999954048088422,0,0,6
503,Male infertility WP4673,0.9231097064253055,0.7283683643832394,0.0582747083116669,"['PIWIL1', 'PACRG', 'ABCB1', 'CCDC36', 'PON1', 'HMGA1', 'PEX10', 'TEX15', 'CLU', 'THBS1', 'SOD3', 'ETV5', 'CYP26B1', 'SPATA17', 'MSH4', 'BCL2', 'AHRR', 'NOS1', 'HORMAD1', 'RAG1', 'SOX5']",0.9999954048088422,0,0,21
504,Wnt signaling WP428,0.9231097064253055,0.7283683643832394,0.0582747083116669,"['WNT10A', 'JUN', 'WNT5B', 'SERPINF1', 'TCF7', 'NFATC3', 'NFATC2', 'DKK1', 'CXXC4', 'DKK2', 'SFRP4', 'WNT6', 'FRAT1', 'CCND3', 'FRAT2', 'SFRP2', 'PPP3R2', 'PLCB4', 'MYC', 'ROR1', 'RAC1']",0.9999954048088422,0,0,21
505,Amino Acid metabolism WP3925,0.9265766592261405,0.6960253242975756,0.05307784441895386,"['AOC3', 'TPH1', 'WARS', 'OAT', 'GOT1', 'MDH2', 'ODC1', 'PYCR1', 'ACLY', 'TPO', 'LDHA', 'PKM', 'P4HA2', 'ALDH1A1', 'ACSS1', 'HIBCH']",0.9999954048088422,0,0,16
506,TGF-beta Signaling Pathway WP366,0.9283760060426076,0.7470553784082775,0.05551999728957477,"['YAP1', 'CDKN1A', 'CITED1', 'ROCK1', 'ITGB4', 'NEDD9', 'THBS1', 'CCNB2', 'PARD6A', 'SUMO1', 'MYC', 'RAC1', 'JUNB', 'SKP1', 'KLF10', 'JUN', 'CDKN2B', 'TGFB1', 'LIMK2', 'FN1', 'FOS', 'TGFBR2', 'TGFBR3', 'RBL1', 'ZEB1', 'CDK1', 'STRAP']",0.9999954048088422,0,0,27
507,T-cell receptor (TCR) signaling pathway WP69,0.9295579025028895,0.6851653580775636,0.050048711742577835,"['JUN', 'CD83', 'TGFB1', 'NFATC2', 'FOS', 'NFKBIA', 'ZAP70', 'CD4', 'GRAP2', 'LCP2', 'IKBKG', 'CD247', 'HRAS', 'MAP3K14', 'MAPK3']",0.9999954048088422,0,0,15
508,Integrated breast cancer pathway WP1984,0.9302523763576258,0.7580372070012624,0.05480560281664073,"['GSK3A', 'TRADD', 'ODC1', 'PHB', 'JAKMIP1', 'TFPI', 'FOXO1', 'EGFR', 'RASGRP3', 'CASP8', 'RRAS', 'CDH1', 'MYC', 'ABL1', 'E2F1', 'RHO', 'FADD', 'RAC1', 'RPP38', 'PLK3', 'JUN', 'GADD45A', 'STAT1', 'BAD', 'TGFBR2', 'FER', 'RAD51', 'BCL2', 'BAX', 'KRAS', 'FAU']",0.9999954048088422,0,0,31
509,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9315667242547843,0.609290050145157,0.04319102438048842,"['ADCY10', 'TGFB1', 'ADCY9', 'CFL1', 'BANF1', 'KRAS', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,8
510,One-carbon metabolism and related pathways WP3940,0.9315667242547843,0.609290050145157,0.04319102438048842,"['DMGDH', 'GPX2', 'GPX4', 'GPX3', 'CHDH', 'DNMT3A', 'SOD3', 'SOD1']",0.9999954048088422,0,0,8
511,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9315667242547843,0.609290050145157,0.04319102438048842,"['CASP8', 'TGFB1', 'STAT1', 'CD160', 'TRADD', 'CXCL17', 'FADD', 'CXCL5']",0.9999954048088422,0,0,8
512,Ethanol effects on histone modifications WP3996,0.9318374834401418,0.522430899270007,0.03688197765583568,"['ALDH1A3', 'AHCY', 'HDAC10', 'ALDH1A1']",0.9999954048088422,0,0,4
513,Triacylglyceride synthesis WP325,0.9329827723905061,0.4840694996859954,0.033579195929539854,"['LIPE', 'LPL', 'AGPAT1']",0.9999954048088422,0,0,3
514,Vitamin D in inflammatory diseases WP4482,0.9329827723905061,0.4840694996859954,0.033579195929539854,"['NFKBIA', 'DUSP1', 'IKBKG']",0.9999954048088422,0,0,3
515,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.933024028498148,0.5484927605032044,0.03802389008711465,"['TICAM2', 'IRAK1', 'PLG', 'PLAT', 'IKBKG']",0.9999954048088422,0,0,5
516,Mesodermal commitment pathway WP2857,0.9378665943040414,0.7284811057943584,0.04673028809965375,"['YAP1', 'ZIC2', 'SESN1', 'C1QBP', 'HNF4A', 'RPL38', 'AMH', 'JAK2', 'TBX1', 'LEFTY1', 'SLC2A12', 'PBX3', 'HMGA2', 'TBX6', 'ELP4', 'DKK1', 'ZFHX4', 'GRHL2', 'EXT1', 'ARL4A', 'KLF5', 'PRKAR1A', 'BHLHE40', 'NABP2', 'NODAL']",0.9999954048088422,0,0,25
517,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9388543620594888,0.42205517442709095,0.026629533575197754,"['FRAT1', 'ROCK1']",0.9999954048088422,0,0,2
518,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.9388543620594888,0.42205517442709095,0.026629533575197754,"['SFRP4', 'DKK3']",0.9999954048088422,0,0,2
519,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9388543620594888,0.42205517442709095,0.026629533575197754,"['ABCA1', 'HMGCS1']",0.9999954048088422,0,0,2
520,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9388543620594888,0.42205517442709095,0.026629533575197754,"['ACLY', 'IDH3A']",0.9999954048088422,0,0,2
521,15q11.2 copy number variation syndrome WP4940,0.9389737653289424,0.34298672041735834,0.02159709832977326,['TUBGCP4'],0.9999954048088422,0,0,1
522,ATR Signaling WP3875,0.9389737653289424,0.34298672041735834,0.02159709832977326,['RAD9A'],0.9999954048088422,0,0,1
523,Biotin Metabolism (including IEMs) WP5031,0.9389737653289424,0.34298672041735834,0.02159709832977326,['ACACB'],0.9999954048088422,0,0,1
524,Serotonin Transporter Activity WP1455,0.9389737653289424,0.34298672041735834,0.02159709832977326,['NOS1'],0.9999954048088422,0,0,1
525,Pathways affected in adenoid cystic carcinoma WP3651,0.9399667701945845,0.6449050376213252,0.0399265579112715,"['CEBPA', 'NOTCH1', 'MYCBP', 'KANSL1', 'CNTN6', 'MYC', 'MAGI2', 'INSRR', 'IL17RD', 'FGFR4', 'HRAS', 'FOXP2']",0.9999954048088422,0,0,12
526,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9416500769629594,0.5927713937215124,0.035638330012466954,"['EIF4A2', 'RPTOR', 'RPS6KA5', 'RPS6KA2', 'RPS6', 'PIM2', 'EIF4B', 'MAPK3']",0.9999954048088422,0,0,8
527,SARS-CoV-2 mitochondrial interactions WP5038,0.9444159213708062,0.4986408939897312,0.028516582208118285,"['NDUFB9', 'PHB', 'PHB2', 'NOX1']",0.9999954048088422,0,0,4
528,Regulation of toll-like receptor signaling pathway WP1449,0.9445585824687694,0.7015376837113618,0.04001400412231301,"['JUN', 'CUEDC2', 'TICAM2', 'CISH', 'STAT1', 'CD80', 'PELI3', 'PELI2', 'FOS', 'NFKBIA', 'CASP8', 'IRAK1', 'TOLLIP', 'TIFA', 'TLR9', 'PTPN6', 'FADD', 'RAC1', 'IKBKG', 'TLR5', 'MAPK3']",0.9999954048088422,0,0,21
529,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9445733733269532,0.5273512388394895,0.030070574996866575,"['NFKBIA', 'JUN', 'STAT1', 'IKBKG', 'FOS']",0.9999954048088422,0,0,5
530,DNA damage response (only ATM dependent) WP710,0.9464753904208738,0.6935189149745811,0.03815069000611402,"['WNT10A', 'JUN', 'CDKN1A', 'TGFB1', 'CDKN1B', 'WNT5B', 'BAD', 'TCF7', 'WNT6', 'FRAT1', 'CCND3', 'MYC', 'ABL1', 'BCL2', 'RAC3', 'BAX', 'KRAS', 'RAC1', 'HRAS', 'PCK2']",0.9999954048088422,0,0,20
531,ErbB signaling pathway WP673,0.9467076924857881,0.6750290648534338,0.03696789943707456,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'BAD', 'GAB1', 'NRG1', 'ELK1', 'FOXO1', 'EGFR', 'NRG3', 'ERBB4', 'MYC', 'ABL1', 'KRAS', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,17
532,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9479950650029648,0.5644530431502927,0.030145169307155616,"['CDKN1A', 'JUN', 'TGFB1', 'RRM2', 'MYC', 'RAC1', 'MAPK3']",0.9999954048088422,0,0,7
533,Splicing factor NOVA regulated synaptic proteins WP4148,0.9479950650029648,0.5644530431502927,0.030145169307155616,"['PLCB4', 'CAV2', 'APLP2', 'STXBP2', 'GRIK2', 'NCDN', 'EFNA5']",0.9999954048088422,0,0,7
534,Regulation of Actin Cytoskeleton WP51,0.9495855432755753,0.7284916152176627,0.037684623434990086,"['CHRM1', 'ROCK1', 'CHRM5', 'PXN', 'BRK1', 'FGF1', 'ACTB', 'EGFR', 'ACTG1', 'RRAS', 'CFL2', 'TMSB4X', 'CFL1', 'RAC3', 'PIP4K2C', 'RAC1', 'WASF2', 'MAPK3', 'F2R', 'RASSF7', 'FN1', 'MSN', 'FGF17', 'VIL1', 'FGF14', 'KRAS', 'FGFR4', 'FGFR3', 'FGF10']",0.9999954048088422,0,0,29
535,Endoderm differentiation WP2853,0.950999507081083,0.706754657190764,0.03550858002223973,"['DUSP4', 'DUSP5', 'DUSP2', 'NOTCH1', 'TGFB1', 'STAT1', 'TCF7', 'ONECUT1', 'SLC2A12', 'PBX3', 'WNT8A', 'ELP4', 'DKK1', 'ZFHX4', 'GRHL2', 'FOXO1', 'GLI2', 'NME1', 'EXT1', 'SESN1', 'C1QBP', 'TCEAL2', 'NABP2', 'NODAL']",0.9999954048088422,0,0,24
536,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9526672625784702,0.39187449173217676,0.019001830943579365,"['MKNK2', 'MAPK3']",0.9999954048088422,0,0,2
537,Glycosaminoglycan degradation WP4815,0.9526672625784702,0.39187449173217676,0.019001830943579365,"['HPSE2', 'HYAL2']",0.9999954048088422,0,0,2
538,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9529717546747151,0.5873638122390795,0.028293323113742025,"['NFKBIA', 'CASP8', 'TKFC', 'TRADD', 'IFNE', 'PIN1', 'ISG15', 'IKBKG', 'FADD']",0.9999954048088422,0,0,9
539,Ras signaling WP4223,0.9538982311059825,0.7386453306625391,0.03486279594294094,"['SHC4', 'FLT1', 'FOXO4', 'ELK1', 'ETS2', 'EGFR', 'IGF1R', 'RASGRP3', 'GNG10', 'GNG3', 'HTR7', 'RRAS', 'ABL1', 'RAC3', 'RAC1', 'IKBKG', 'HRAS', 'MAPK3', 'NTRK1', 'PLA2G4E', 'PLA2G2C', 'BAD', 'GAB1', 'KSR2', 'GNG11', 'ZAP70', 'RASA4', 'CALM3', 'KRAS', 'CALM1', 'FGFR4', 'CALM2', 'FGFR3', 'ARF6']",0.9999954048088422,0,0,34
540,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9542902818218132,0.5077757558175313,0.023757494793722293,"['NFKBIA', 'PPP3R2', 'SUPT4H1', 'NFATC3', 'NFATC2']",0.9999954048088422,0,0,5
541,Intraflagellar transport proteins binding to dynein WP4532,0.9548356797115105,0.4769195848207837,0.022041323370381224,"['IFT140', 'DYNLT3', 'DYNLL1', 'DYNLL2']",0.9999954048088422,0,0,4
542,Resistin as a regulator of inflammation WP4481,0.9548356797115105,0.4769195848207837,0.022041323370381224,"['NFKBIA', 'PLCB4', 'IKBKG', 'MAPK3']",0.9999954048088422,0,0,4
543,LTF danger signal response pathway WP4478,0.955277366783906,0.3048507364371723,0.013948001658297073,['IRAK1'],0.9999954048088422,0,0,1
544,Non-homologous end joining WP438,0.955277366783906,0.3048507364371723,0.013948001658297073,['DCLRE1C'],0.9999954048088422,0,0,1
545,TCA cycle in senescence WP5050,0.955277366783906,0.3048507364371723,0.013948001658297073,['GOT1'],0.9999954048088422,0,0,1
546,Fatty Acid Biosynthesis WP357,0.9573876644913301,0.4330398951114441,0.018857539158118317,"['ACLY', 'ACSL5', 'ACACB']",0.9999954048088422,0,0,3
547,Non-small cell lung cancer WP4255,0.9576117500107046,0.6249285520579093,0.027067439475360174,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'FHIT', 'EGFR', 'CASP8', 'E2F1', 'CYCS', 'BAX', 'KRAS', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,13
548,DNA Repair Pathways Full Network WP4946,0.9606407959082587,0.6917551389202621,0.027777234920954217,"['FANCI', 'FEN1', 'DCLRE1C', 'CENPX', 'MPG', 'CETN2', 'H2AFX', 'RPA2', 'RAD23A', 'GTF2H5', 'FANCF', 'POLE4', 'POLD4', 'BRIP1', 'NEIL2', 'RAD51', 'POLD1', 'RPA3', 'POLE2', 'APEX1', 'POLD2', 'POLE3', 'USP1', 'POLE']",0.9999954048088422,0,0,24
549,MET in type 1 papillary renal cell carcinoma WP4205,0.9619484549932367,0.5830838928889248,0.022620396094954438,"['CDKN1A', 'JUN', 'BAD', 'HGF', 'RPL11', 'GAB1', 'KRAS', 'RAC1', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,10
550,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9634647832724806,0.3657179000632511,0.013611779827879006,"['ACADL', 'CPT2']",0.9999954048088422,0,0,2
551,EGF/EGFR signaling pathway WP437,0.9636713441207075,0.7178965012179552,0.026565739809146418,"['NDUFA13', 'PTPRR', 'ROCK1', 'PEBP1', 'NEDD8', 'FOXO4', 'ELK1', 'FOXO1', 'EGFR', 'RPS6KA5', 'RPS6KA2', 'CFL1', 'STMN1', 'ABL1', 'E2F1', 'AP2S1', 'RAC1', 'JAK2', 'HRAS', 'MEF2D', 'AP2M1', 'JUN', 'CAV2', 'STAT1', 'LIMK2', 'GAB1', 'FOS', 'EPN1', 'NEDD4', 'SPRY2', 'KRAS', 'ARF6']",0.9999954048088422,0,0,32
552,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9655149971455191,0.6186044013382033,0.021709082760479455,"['EDN1', 'TGFB1', 'CISH', 'ROCK1', 'NRG1', 'IGF1R', 'NPPA', 'RAC1', 'IKBKG', 'CALM1', 'CALM2', 'MAP3K14', 'PRKG1', 'MAPK3']",0.9999954048088422,0,0,14
553,TLR4 Signaling and Tolerance WP3851,0.9661910975572295,0.4113523131672598,0.014147903691414509,"['NFKBIA', 'IRAK1', 'IKBKG']",0.9999954048088422,0,0,3
554,Trans-sulfuration and one-carbon metabolism WP2525,0.9661910975572295,0.4113523131672598,0.014147903691414509,"['AHCY', 'DNMT3A', 'MAT2B']",0.9999954048088422,0,0,3
555,Alanine and aspartate metabolism WP106,0.9672259488309178,0.27434194925302346,0.009141938262417153,['GOT1'],0.9999954048088422,0,0,1
556,Biogenic Amine Synthesis WP550,0.9672259488309178,0.27434194925302346,0.009141938262417153,['TPH1'],0.9999954048088422,0,0,1
557,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.9672259488309178,0.27434194925302346,0.009141938262417153,['TPO'],0.9999954048088422,0,0,1
558,Glioblastoma signaling pathways WP2261,0.9677335818532731,0.622553154673069,0.020418781594535966,"['CDKN1A', 'CDKN2B', 'CDKN1B', 'PRKCH', 'CDKN2C', 'GAB1', 'FOXO4', 'FOXO1', 'EGFR', 'IGF1R', 'E2F1', 'SPRY2', 'KRAS', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,15
559,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9722690513256,0.5591875533483356,0.015725869984974893,"['IFI27L2', 'JUN', 'PRKCH', 'PLCB4', 'STAT1', 'ISG15', 'KRAS', 'HRAS', 'RELB', 'MAPK3']",0.9999954048088422,0,0,10
560,Signal Transduction of S1P Receptor WP26,0.9732565226514699,0.3917302152177597,0.01061886229428269,"['SPHK1', 'S1PR2', 'MAPK3']",0.9999954048088422,0,0,3
561,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9735448417672845,0.5686210314345812,0.01524552183340506,"['ACLY', 'IDI1', 'SQLE', 'GSK3A', 'RBP4', 'HMGCS1', 'INSIG1', 'PRKAG2', 'LPL', 'PPARG', 'ACSS1']",0.9999954048088422,0,0,11
562,G Protein Signaling Pathways WP35,0.9736493924971824,0.6171708978286664,0.01648093583909695,"['GNAZ', 'PRKCH', 'AKAP5', 'GNG11', 'GNG10', 'GNG3', 'GNA15', 'ADCY9', 'RRAS', 'PRKD3', 'PRKAR1A', 'KRAS', 'PRKD1', 'CALM1', 'HRAS', 'CALM2']",0.9999954048088422,0,0,16
563,DNA IR-damage and cellular response via ATR WP4016,0.9740011399684423,0.5991689462416746,0.015783790677833844,"['FANCI', 'FEN1', 'ABRAXAS1', 'H2AFX', 'RPA2', 'FOXM1', 'BRIP1', 'RAD51', 'E2F1', 'USP1', 'CDK1', 'IKBKG', 'MCPH1', 'RAD9A']",0.9999954048088422,0,0,14
564,NO metabolism in cystic fibrosis WP4947,0.9759826177853289,0.24938021428417445,0.006062558291338563,['NOS1'],0.9999954048088422,0,0,1
565,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.978395312371396,0.32263645496149124,0.007046859529399341,"['DNMT3A', 'BCL2']",0.9999954048088422,0,0,2
566,Monoamine Transport WP727,0.9789045184747164,0.3738919443545778,0.007971814027206673,"['ADORA2A', 'TNFRSF11B', 'NOS1']",0.9999954048088422,0,0,3
567,Fragile X Syndrome  WP4549,0.9800214040139881,0.6406050341764192,0.012927964818351824,"['GRIA1', 'GABRA1', 'DUSP3', 'HOMER1', 'KCND2', 'BDNF', 'GAB1', 'AKAP5', 'GRM1', 'DNM2', 'RPTOR', 'GRIP1', 'ARC', 'GRM5', 'PRKAR1A', 'CLTCL1', 'AP2S1', 'KRAS', 'DLGAP3', 'GABRD', 'AP2M1', 'SHANK1']",0.9999954048088422,0,0,22
568,GPR40 Pathway WP3958,0.9823999002980525,0.22857876847680025,0.0040588327510931955,['ITPR3'],0.9999954048088422,0,0,1
569,Omega-3/Omega-6 FA synthesis WP4723,0.9823999002980525,0.22857876847680025,0.0040588327510931955,['ELOVL2'],0.9999954048088422,0,0,1
570,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9826003972689422,0.4567505539727762,0.008017230544348256,"['RPTOR', 'MAP1LC3A', 'ATG101', 'GTPBP2', 'CP', 'FTL']",0.9999954048088422,0,0,6
571,Ectoderm Differentiation WP2858,0.9846228059980019,0.6375821214772838,0.009880386487166614,"['TTC14', 'NLGN1', 'EDA', 'HDAC10', 'ELOVL2', 'ARHGDIG', 'STC1', 'PRKAG2', 'TNFRSF11B', 'SORCS1', 'POU2F2', 'JAKMIP1', 'CELSR2', 'ZFHX4', 'VAX2', 'GLI3', 'PPFIBP2', 'MYC', 'HESX1', 'SPRY2', 'DMD', 'CTNNA2', 'LY6E', 'CLVS1']",0.9999954048088422,0,0,24
572,IL-1 signaling pathway WP195,0.9852701284680773,0.4870519926101874,0.007227575561851902,"['NFKBIA', 'JUN', 'IRAK1', 'TOLLIP', 'PELI2', 'IKBKG', 'MAP3K14', 'MAPK3']",0.9999954048088422,0,0,8
573,Ciliary landscape WP4352,0.9853789805250901,0.7038129728566819,0.010366433128854356,"['YAP1', 'SSNA1', 'VPS4A', 'USH1C', 'HTRA2', 'COPS7A', 'MYL6B', 'IQGAP2', 'PSMD8', 'PSMD7', 'EXOSC4', 'ARHGDIA', 'NEFL', 'BBS9', 'NEFM', 'TMED1', 'SNRPB2', 'RAC1', 'DCAF11', 'EXOC8', 'NDUFA5', 'IFT140', 'WHRN', 'DYNLT3', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'MKLN1', 'MYL6', 'COPS6', 'RAB14', 'TTC30A', 'GID8', 'MCM3', 'CD2BP2', 'MCM4', 'EFHC2', 'CALM1', 'COPS8', 'CALM2', 'GLA', 'ARL8B']",0.9999954048088422,0,0,43
574,Omega-9 FA synthesis WP4724,0.9871026621058856,0.2109775451013298,0.0027387481783256464,['ELOVL2'],0.9999954048088422,0,0,1
575,Wnt Signaling Pathway WP363,0.9879046370158773,0.4566215467426581,0.0055566765209696745,"['GSK3A', 'FRAT1', 'MYC', 'NFATC2', 'PPARG', 'ROR1', 'RAC1']",0.9999954048088422,0,0,7
576,MECP2 and Associated Rett Syndrome WP3584,0.9898478299593614,0.4979260283442793,0.0050808644693172665,"['GRIA1', 'MPP1', 'REST', 'BDNF', 'RPS6', 'E2F1', 'TAP1', 'SGK1', 'IGF1R', 'FKBP5']",0.9999954048088422,0,0,10
577,Integrin-mediated Cell Adhesion WP185,0.9902987236837507,0.5614420483530431,0.005473296563806502,"['CAV3', 'ROCK1', 'CAV2', 'ITGB4', 'PXN', 'CAPNS1', 'ITGA10', 'ITGA11', 'ITGA8', 'RHO', 'RAC3', 'ITGB8', 'CAPN1', 'RAC1', 'ITGA5', 'HRAS']",0.9999954048088422,0,0,16
578,Nanoparticle triggered autophagic cell death WP2509,0.9903275783012305,0.2741698292220114,0.002664794590489094,"['MAP1LC3A', 'BCL2']",0.9999954048088422,0,0,2
579,Energy Metabolism WP1541,0.9904748805074928,0.42150631894221635,0.004034141541799454,"['PPP3R2', 'UCP3', 'PRKAG2', 'PPARG', 'MEF2D', 'FOXO1']",0.9999954048088422,0,0,6
580,Insulin Signaling WP481,0.9914214550560129,0.6343585581284316,0.005465349435849892,"['ARF1', 'GSK3A', 'STXBP2', 'ELK1', 'FOXO1', 'IGF1R', 'GYS2', 'LIPE', 'SOCS3', 'GYS1', 'RPS6KA5', 'RPS6KA2', 'ENPP1', 'RAC1', 'GYG1', 'HRAS', 'SH2B2', 'MAPK3', 'EGR1', 'XBP1', 'JUN', 'PRKCH', 'GAB1', 'FOS', 'SGK1', 'MAP3K14', 'SGK2', 'PFKM', 'ARF6']",0.9999954048088422,0,0,29
581,miRNA regulation of p53 pathway in prostate cancer WP3982,0.9926262351095039,0.2610915333875486,0.00193236075707684,"['CASP8', 'BAX']",0.9999954048088422,0,0,2
582,SARS coronavirus and innate immunity WP4912,0.9930742619726355,0.18281558770057704,0.0012705376694576258,['STAT1'],0.9999954048088422,0,0,1
583,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.9943870648850498,0.24920217353803692,0.0014026959442723908,"['STAT1', 'TLR9']",0.9999954048088422,0,0,2
584,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9943870648850498,0.24920217353803692,0.0014026959442723908,"['MYC', 'DKK1']",0.9999954048088422,0,0,2
585,Wnt signaling in kidney disease WP4150,0.9951613566682935,0.2936197254702593,0.001424169436029877,"['WNT6', 'WNT10A', 'WNT5B']",0.9999954048088422,0,0,3
586,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9962807666932779,0.16127997321764845,0.0006009560900795697,['MAP1LC3A'],0.9999954048088422,0,0,1
587,Glycerophospholipid Biosynthetic Pathway WP2533,0.9981393694499733,0.21079039556269158,0.00039256837535193555,"['PTPMT1', 'CDIPT']",0.9999954048088422,0,0,2
588,ESC Pluripotency Pathways WP3931,0.9982641987175109,0.48259646471008105,0.0008384194378326551,"['WNT10A', 'JUN', 'WNT5B', 'GAB1', 'FOS', 'FGF1', 'ELK1', 'EGFR', 'FGF17', 'WNT6', 'FGF14', 'FGFR4', 'FGFR3', 'HRAS', 'FGF10']",0.9999954048088422,0,0,15
589,Chemokine signaling pathway WP3929,0.9984455737313767,0.5206107216588398,0.0008098805945078253,"['SHC4', 'ROCK1', 'STAT1', 'PXN', 'GNG11', 'CXCL5', 'NFKBIA', 'HCK', 'GNG10', 'GNG3', 'ADCY9', 'PLCB4', 'GRK5', 'KRAS', 'RAC1', 'IKBKG', 'JAK2', 'DOCK2', 'HRAS', 'MAPK3']",0.9999954048088422,0,0,20
590,Glycerolipids and Glycerophospholipids WP4722,0.9985357574387491,0.1370524069243538,0.00020082503152691483,['CDIPT'],0.9999954048088422,0,0,1
591,Kallmann's Syndrome WP5074,0.9985357574387491,0.1370524069243538,0.00020082503152691483,['PROKR2'],0.9999954048088422,0,0,1
592,Phosphoinositides metabolism WP4971,0.9986499166377757,0.24902404831230454,0.0003364303800857346,"['PIP4P1', 'PLCB4', 'PIP4K2C']",0.9999954048088422,0,0,3
593,Joubert Syndrome WP4656,0.9991529936817904,0.3847224697077691,0.0003260004443158882,"['TMEM17', 'KAT5', 'CETN2', 'SUFU', 'BBS9', 'ARL2', 'PDE6A', 'B9D2', 'ATF4']",0.9999954048088422,0,0,9
594,Rett syndrome causing genes WP4312,0.9996657742826571,0.24884583854683523,8.318458088370023e-05,"['SRRM3', 'EIF2B2', 'IMPDH2', 'GABRD']",0.9999954048088422,0,0,4
595,Wnt signaling pathway and pluripotency WP399,0.999797196974261,0.37582897551699546,7.622698318795976e-05,"['WNT6', 'FRAT1', 'CCND3', 'WNT10A', 'JUN', 'PRKCH', 'WNT5B', 'MYC', 'TCF7', 'PPM1J', 'PRKD1']",0.9999954048088422,0,0,11
596,Ciliopathies WP4803,0.9997988767957636,0.5080147113272283,0.00010218382265475002,"['DNAH6', 'PKD1L1', 'CCDC28B', 'GLI3', 'GLI2', 'PKHD1', 'ZIC2', 'SUFU', 'HYDIN', 'CNGA1', 'BBS9', 'NEK2', 'PLK4', 'DNAH11', 'RSPH4A', 'IFT140', 'CFAP410', 'TMEM17', 'EVC', 'SMO', 'MAK', 'CCDC65', 'B9D2', 'CCNQ', 'CCDC151', 'CCNO', 'CNGB1']",0.9999954048088422,0,0,27
597,mRNA Processing WP411,0.9999555577726955,0.39700575483535977,1.764421207452826e-05,"['SF3B5', 'SF3A1', 'NCBP2', 'CSTF2T', 'SNU13', 'LSM2', 'LSM7', 'HNRNPK', 'SNRPD1', 'SNRPG', 'CD2BP2', 'SRSF3', 'SNRPE', 'SNRPB2', 'HNRNPA1', 'SRSF9']",0.9999954048088422,0,0,16
598,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9999827467837714,0.3570431364877242,6.160195578501025e-06,"['GSK3A', 'DIO2', 'LPL', 'PRKAG2', 'CYP3A4', 'FOXO1', 'RPTOR', 'GYS1', 'RPS6KA5', 'RPS6KA2', 'MAP3K14', 'HRAS', 'FBP1', 'MAPK3']",0.9999954048088422,0,0,14
599,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999954048088422,0.23217263860110174,1.0668801072456142e-06,"['TMEM17', 'EVC', 'IFT140', 'CDK20', 'BBS9', 'TULP3', 'CEP162', 'DYNLL1']",0.9999954048088422,0,0,8
